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ABSTRACT
The whole grain and fat content of the diet have been previously shown to affect
intestinal fermentation and phenotype conferred by high–amylose maize resistant starch
(HAMRS), a form of fermentable dietary fiber. The current studies were designed to compare
rodent gut health following consumption of whole grain and non–whole grain prebiotics on
moderate fat (MF) and high fat (HF) diets, and to optimize health effect based on dosage of
whole grain resistant starch prebiotics.
Study 1: Diets were prepared to contain the following factors RS (Present/Absent), WG
(Present/Absent), and Fat (HF/MF). A three–way ANOVA was performed with statistical slice
on interactions and main effects. Study 2: Isocaloric diets (3.7 kcal/g) were prepared as follows:
non–RS non–WG control, non–RS WG control, or with increasing WGRS (5, 10, 15, 20% wt.)].
One–way ANOVA with a priori contrasts (WG vs. all individually) were performed at p<0.05
Both: Diets were fed to Sprague Dawley and lean Zucker Diabetic Fatty rats respectively, for six
weeks. After euthanasia, blood, cecal contents and cecal epithelial cells were collected and
gastro–intestinal (GI) tract portions and fat pad weights recorded. RT–qPCR was performed to
analyze gluconeogenic enzymes, response to oxidative stress, and gut barrier resilience.
For study 1, a few interactions were significant, but the RS main effect provided the most
substantial changes in biometric and gene expression parameters. WG presence resulted in
consistency of fermentation. Results were primarily driven by two major effects: purified RS
fermented better on MF than HF diets and diets with RS+WG show similar fermentation on both
levels of dietary fat.
Although the 10–15% dosages were best for initiating benefits from fermentation in study
2, WG flour alone promoted fermentation with RS1 (a WG kernel component), and WGRS

xii

(RS1+RS2) promoted greater fermentation. Replacing traditional starch with a whole grain with
resistant starch, as low as 5%, had some beneficial effects. These results suggest that a lower
level of intake of fermentable fiber as RS is beneficial, but show that substantial WG (only low
RS1) also had beneficial effects.

xiii

CHAPTER 1. INTRODUCTION
1.1. Significance of Research
Nutritional policies and recommendations regarding an adequate level of fiber (38 g/day
and 25 g/day for men and women respectively) [1] have not been successfully met as most
Americans fail to meet even half the Adequate Intake [2]. New approaches must be employed to
maximize nutritional benefits within this reduced fiber consumption profile. Fiber itself is not a
singular substance and is understood to have complex chemical arrangements with a variety of
functions. One function is the degree to which the fiber is fermentable. Fermentable fiber has a
greater bioactive or biological effect than a non–fermentable fiber. It can act as a prebiotic to
promote gut health by elevating the growth of beneficial bacteria, which increases the production
of short–chain fatty acids [3–5].
The recommendations for dietary fat intake are within an acceptable macronutrient
distribution range (AMDR) between 20% and 35% of energy [1], and the average dietary fat
intake for Americans is approximately 33% of energy [6]. Studies examining the effects of fat
intake on changes in the microbiota have focused on low fat (18–20% of energy) or very high fat
(60–70% of energy) diets [7, 8]. The effects of high fat diets on the gut microbiota and the host
have been characterized, with a reduction in fermentation as a primary result [9].
Simultaneously, there exists a void in the literature when examining the effects of a moderate fat
diet on gut health. However, our lab group has begun to address this issue. In one study, we
examined the effects of a moderate fat (26% of energy) diet, and found that low and moderate fat
diets had similar effects on the fermentation of a non–whole grain resistant starch prebiotic fiber
for reducing body fat [10] and improving bacterial population (unpublished data). However, a
robust characterization of fermentation parameters produced from intake similar to what
Americans consume (moderate fat versus high fat) does not currently exist.
1

Recommendations for whole grains initially appeared in the Dietary Guidelines for
Americans 2005 [11], and current recommendations promote making at least half the grains
consumed whole grains. As with many recommendations, Americans do not meet the federal
dietary recommendations, and this is especially true for whole grains [12]. While no consensus
on whole grain consumption has been reached, many reports describe a correlation with whole
grain consumption and better health [13, 14].
It is important to determine how these bioactive components act individually, but as well
as also how they interact with each other within a dynamic system dedicated to maintaining
homeostasis. Characterizing how fat intake at levels similar to the typical American diet affect
gut health remains incomplete. Determining how moderate fat diets compare to low and high fat
diets needs to be examined. Similarly, simplifying whole grains to a singular substance begets
the confusion regarding fiber. Yet, other questions remain unanswered. Can other bioactive
components mitigate negative effects associated with high fat diets? Our lab is interested in
investigating if lower levels of fiber intake (in the form of fermentable fiber) than the current
recommendations promote a healthy gut phenotype when fed as part of a moderate fat diet
comparable to the average dietary fat intake for Americans. In the future, more people may be
able to benefit from these bioactive components without drastically altering their diet. Of course,
those who partake in more of these components may see more benefits, but those who do not
may still benefit even at reduced levels of intake.
1.2. Objectives
1. Use three bioactive components (resistant starch, whole grains, and fat) to improve gut
health.
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2. Determine if moderate dietary fat consumption provides greater health effects than high
dietary fat consumption.
3. Determine if a whole grain version of resistant starch is more efficacious than a non–
whole grain resistant starch.
4. Examine how gene expression changes in response to fermentation of dietary fermentable
fibers.
5. Determine the optimal dose for a whole grain resistant starch product to elicit changes to
biometric, fermentation, and gene expression parameters.

3

CHAPTER 2. LITERATURE REVIEW
2.1. Resistant Starch
Dietary fiber is defined as the “non–digestible carbohydrates and lignin that are intrinsic
and intact in plants [15].” The non–digestible carbohydrates can include inulin, oligosaccharides,
fructans, methylcellulose, polydextrose, resistant maltodextrose, resistant starch, and other
compounds. The property of a starch depends on the arrangement of glycosidic bonds linking
the glucose monomers that make up the amylose or amylopectin molecules in the granule. Using
in vitro assays, Englyst et al. (1992) classified starches into three fractions: (1) rapidly digestible
starch, digested to glucose within 20 minutes, (2) slowly digestible starch, digested between 20
and 120 minutes, and (3) resistant starch, any starch remaining after 120 minutes [16]. One
function of dietary fiber is the degree to which it is fermentable. Resistant starch is one such
fermentable fiber. In the early days of fiber research, observational studies noted a decreased
risk for colorectal cancer and other bowel diseases after consuming a diet high in unrefined
grains and cereals, attributed primarily to dietary fiber. Cassidy et al. (1994) reported one such
benefit of consuming resistant starch finding a “strong inverse association between starch
consumption and large bowel cancer incidence” [17]. Topping et al. (2001) agreed, but further
attributed the benefits found in those studies primarily to resistant starch and to a lesser degree,
non–starch polysaccharides [18].
Resistant starch resists enzymatic digestion in the small intestine and is fermented by
bacteria in the large intestine [19]. Resistant starch can be classified into four major types.
Resistant starch 1 (RS1) is a component of whole– and partially milled grains, seeds and
legumes. The RS1 is found in the starch granule, and the intact cell wall enclosing the granule
physically limits accessibility to enzymatic hydrolysis. Resistant starch 2 (RS2) is a highly
compacted starch in granules with reduced accessibility to enzymes that digest the glycosidic
4

bonds. The RS2 found in raw starch can be gelatinized after heating, allowing amylases access
to the starch and thus, the starch becomes digestible. High–amylose maize (HAM) is high in
RS2 due to the high amylose content and having a higher gelatinization temperature that
increases its resistance against enzymatic hydrolysis.

Resistant starch 3 is formed by

retrograded (gelatinized and crystallized) amylose and amylopectin. When heated, the starch’s
crystalline structures dissociate. Upon cooling, the crystalline structures are restored, returning
stability to the molecule. Resistant starch 4 is a chemically modified starch. Modifications can
emanate from direct addition of functional groups or cross–linking other chemical reagents to
starch using novel bonds other than α–(1–4) and α–(1–6) glycosidic linkages [20]. Recently,
another fraction of resistant starch, resistant starch 5, has been described. Resistant starch 5 is
produced from the addition of lipid complexes (free fatty acids) to amylose. The pairing leads to
a helical structure that is resistant to enzymatic hydrolysis [21].
The fraction of starch that escapes enzymatic digestion in the small intestine, resistant
starch, is potentially capable of being fermented by the gut microbes in the large intestine.
Fermentation of resistant starch stimulates the growth and maintenance of the gut microflora
[22]. In this capacity, resistant starch is considered to be a prebiotic, because it is a non–
digestible food component that provides benefits to the host via microbial fermentation. The end
products of resistant starch fermentation are gases (CO2, H2 and CH4), heat, and short–chain fatty
acids (SCFAs), primarily acetic, propionic, and butyric acid, commonly called acetate,
propionate, and butyrate. Through these SCFAs, resistant starch has been shown to provide
many health benefits. Short–chain fatty acids contribute to gut health by improving energy
homeostasis and metabolism, preventing pathology in the lumen, reducing risk for a variety of
colon cancers, gastrointestinal (GI) disorders, and cardiovascular diseases [18, 23–25].

5

The short–chain fatty acids vary in mode and site of actions. Acetate and propionate
produced in the colon can be found in the small and large intestines, and portal, hepatic and
peripheral blood [26]. The two SCFAs are utilized by peripheral tissues (muscle, acetate) or by
the liver (acetate, propionate) for metabolism [27–30]. Butyrate is especially important for gut
health, and is a major source of energy for epithelial colonocytes [26]. Furthermore, acetate and
lactate produced by bacteria in the gut can be utilized by bacteria in the Clostridium cluster IV,
Clostridium cluster XIV and other genera to produce butyrate [31, 32].

Resistant starch

fermentation provides benefits to the host mediated through the production of SCFAs.
2.2. Whole grains
Initially, a food or product containing more than 25% whole grain or bran content could
be defined as whole grain. This definition included high fiber bran cereals, and did not precisely
calculate the amount of whole grain present [33]. The newer definition, established with the
Food and Drug Administration Modernization Act (1997), set the criteria for manufacturers to
make health claims regarding whole grains. Under these criteria, a whole–grain food is one that
contains more than “51% or more whole grain ingredient(s) by weight per reference amount
customarily consumed [34, 35].”
A whole grain kernel consists of three parts: the bran, the germ, and a starchy endosperm.
For a food to be considered whole grain, the bran, germ, and endosperm must be present in
relative proportions as found naturally in the kernel [35]. Current recommendations for whole
grain consumption call for at least half the grains consumed to be whole grains [36].

Whole

grains have been associated with reduced risk for cardiovascular disease, type 2 diabetes [37,
38], cancers[39–41], and all–cause mortality [42, 43].
While the benefits of whole grains are numerous, it is not immediately clear if the
benefits stem from the fiber or phytochemicals present. As previously mentioned, consumption
6

of dietary fiber in unrefined grains and cereals is associated with reduced risk for several types of
cancer and bowel diseases [39]. Similarly, phytochemicals have also been shown to provide
protection against developing chronic diseases and cancers [44]. Phytochemicals, chemicals
derived from plants, are a large class of compounds that represent thousands of possibly
bioactive molecules. Phytochemicals include carotenoids, organosulfur compounds, alkaloids,
phenolics and other nitrogen–containing compounds [45].
Research regarding phytochemicals focuses primarily on prevention, while fiber research
focuses on risk reduction [45, 46]. These concepts, while similar in thought, differ in execution.
Risk reduction focuses on strategies that mitigate harm to people who are potentially susceptible.
Furthermore, risk reduction focuses on reducing expected loss from a specific type of risk (e.g.
aphasia from a stroke). Prevention strategies focus on reducing the likelihood of an event
occurring.

Although fiber and phytochemical research does overlap, the research for both

fractions examines a different endpoint. Whole grain research can combine these strategies to
examine benefits to health. Some suggest that without the fiber component of whole grains, the
effect would be minimal [33]. This suggestion has not been explicitly tested, as the process of
separating the components would result in a product that is not whole grain.
Whole grains are capable of fermentation as is resistant starch.

Similarly, this

fermentation occurs in the large intestine by gut microbes and promotes the production of
SCFAs, gases and heat. Both the fiber component and the phytochemical component of whole
grains have the capacity for fermentation, although some portions of the whole grain kernel may
be non–fermentable (e.g. cellulose).

Despite the benefits derived from consumption and

fermentation, whole grain intake has remained less than one–third of the recommendation [47].
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However, more research is needed to elucidate the role of whole grains as both a standalone
component and mode of action affected by other nutrients and systems in the body.
2.3. Fat
Fat is a necessary macronutrient required for normal operation of the body. Fat is a
convenient and economical way to store energy in the body, but has functions well beyond the
notable energy storage. Fat is required for: (1) proper functioning of nerve cells [48], (2)
transport of vitamins A, D, E, and K [49–51], and (3) formation of some steroid hormones [52].
Dietary fat consists primarily of triacylglycerol molecules with one glycerol molecule with three
esterified fatty acid molecules attached. Dietary fats differ in many properties including degree
of saturation, cis–trans isomerism, variability in attached moiety, and conjugation.
Dietary fat has many effects on whole body health. There is evidence that some low fat,
high carbohydrate diets may modify lipoprotein and glucose/insulin metabolism in such a way
that risk for chronic disease increases [53]. Krauss (2001) described a low fat, high carbohydrate
diet lipoprotein profile, or atherogenic lipoprotein phenotype, that is minimally expressed in
healthy individuals, but is promoted in sedentary, overweight/obese populations. This profile is
associated with increased risk for coronary heart disease (CHD) when expressed in the general
American population [54]. Although the diet was low in fat, it was also high in simple sugars as
the carbohydrate source.

Thus, the diet was low in fiber which, may contribute to the

atherogenic lipoprotein phenotype. Diets high in fat, where fat is the major source of excess
energy, tend to be energy dense. These diets consumed in excess exacerbate energy control in
obese or overweight persons. Mechanisms influencing energy density’s effect on total energy
intake have been explored.
One tenet confounding the role of fat in promoting chronic disease is the designation of
total energy intake in comparison to percentage of fat. Diets may be high or low in fat, but may
8

or may not alter total energy intake. The terms hypocaloric, isocaloric, and to a lesser extent,
hypercaloric impart a distinction that is important in understanding the impact of fat on body
weight. Roy et al. (2003) tested if adult female rats would adapt to lower and higher energy
density at the same level of fat. Rats in the study adjusted food intake to defend a body weight
previously adapted to a high or low energy density [55].
Regarding dietary fat content in fermentation studies in rodents, most focus on the
extreme positions. Studies focus on low (18–20% of energy) and very high (60–70% of energy)
dietary fat diets [7, 8], neglecting an intake representative of the average American (~33% of
energy). Perhaps this neglect comes from the desire to design mechanistic studies that aim to
tease out a specific outcome with a specific independent variable. Still, high fat diets (>40% of
energy) have been shown to attenuate the beneficial effects of fermentation [9]. It is suspected
that the impact of consuming a moderate fat diet (~30% of energy) on fermentation and body fat
will lie between the low and high fat diets.
2.4. Factor Comparisons
Studies have focused on producing resistant starch from various components, examining
whether whole grains are efficacious or not, and testing how fat affects the diet. Few studies
attempt to compare resistant starch, whole grains, or fat as factors that may affect each other.
For example, Lopez et al. (2000) showed that resistant starch improved mineral absorption from
wheat bran [56] and Behall et al. (2006) tested plasma glucose and insulin responses after the
addition of resistant starch and barley β–glucan to the diets of men [57] and women [58]. Still,
considering the potential combinations of the five resistant starch types and hundreds of
compounds that make up whole grains (vitamins, minerals, phytochemicals, lignans, fiber,
phenolics, phytosterols, etc.), only a few studies have attempted to compare how these bioactive
components interact.

Furthermore, of the few studies that do attempt to compare the
9

components, many are not mechanistic in nature. It is important to understand how these factors
work alone, yet nutrients have polyvalent effects [59]. To this degree, many studies have
examined the effects of these factors at low or extremely high doses. This includes studies using
resistant starch, whole grains, or fat. Studies that examine how bioactive components interact
with each other at physiological doses similar to a typical human (American) diet are needed. A
more complete characterization of how moderate and fat diets affect fermentation and gut health
in a rodent model is required. Similarly, more exploration is needed to understand how other
nutritional components, such as whole grains, influence fermentation and health.
2.5. Reference Gene Expression
The measurement of gene expression is important because it is one part of the path from
gene to functional protein in biological systems [60–62]. Genes are the functional unit of
heredity and are made of DNA. Gene expression spans the processes of transcription and
translation; starting from DNA to messenger RNA (mRNA) to proteins. Although most genes
do not code for proteins, they are integral for control of other gene activity. For gene expression
experiments, researchers are interested in determining how expression of a gene changes under
experimental conditions. Messenger RNA transcripts exported out of the cell nucleus are used as
templates for the basis of gene expression experiments.

These experiments are termed

polymerase chain reaction (PCR), since they exponentially amplify minute DNA sequences to
larger quantities of DNA. However, gene expression experiments typically use a combination of
variants of PCR, termed real–time PCR (qPCR), reverse transcription PCR (RT–PCR), and the
combined technique reverse transcription real–time PCR (RT–qPCR).

Quantitative reverse

transcription PCR, (RT–qPCR) uses RNA as the starting material to be reverse transcribed to
complementary DNA (cDNA). This reverse transcription is required, because DNA is amplified
in PCR. Quantifying the mRNA of a sample in this way is known as gene expression analysis.
10

Expression alone does not provide an accurate indication of gene activity. Researchers
look to compare the gene targeted under various experimental conditions. In order to do this, a
reference gene (RG) is used for generating equivalent comparisons, a process called
normalization. This reference gene (RG), previously known as a housekeeping gene, should be
stably expressed, as any variation to the normalizer will invariably produce artifacts [63].
Reference genes should have non–regulated constitutive (constant) stable expression and must
exhibit equivalent expression under different treatment conditions [64]. Bustin et al. (2002)
describe how glyceraldehyde–3–phosphate dehydrogenase (GAPDH) [65], although commonly
used, should not be considered for most experimental conditions because mRNA levels of
GAPDH are not always constant [66]. Moreover, RGs normally thought to provide stable
expression have been shown not to retain that stability under broader testing conditions [67].
Due to the limitations of stability in RGs, guidelines have been established to aid
researchers for publishing results of gene expression analyses where RGs are vetted through
selection and validation techniques [68].

These guidelines also recommend avoiding

normalization with a single RG, unless the RG has been confirmed to be invariant under the
described testing conditions. New techniques for normalization have been developed to aid with
testing and validation of RGs. Software packages for selecting between several candidate genes,
such as geNORM or BestKeeper, aim to provide accurate normalization of RT–PCR data using
the geometric mean of multiple reference genes [67, 69]. Use of such strategies has been
recently employed to successfully incorporate PCR efficiency with amplification efficiency to
reduce error when normalizing RT–qPCR data.
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CHAPTER 3. A STUDY OF THREE INDEPENDENT DIETARY FACTORS
IN SPRAGUE DAWLEY RATS: RESISTANT STARCH, WHOLE GRAIN
AND FAT (MODERATE, 30%, OR HIGH, 42%)
3.1. Introduction
Nutritional recommendations for fiber and whole grain consumption suggest amounts
that will deliver optimal nutrition to the consumers who stand to benefit from them [70]. These
policies promote increased fiber and whole grain consumption, and decreased fat intake
(Acceptable Macronutrient Distribution Range estimated for total fat is 20 – 35% of energy),
specifically saturated and trans fatty acids [1] . The health benefits of fiber and whole grains
have been increasingly studied in recent years. Epidemiological studies continue to demonstrate
inverse associations between biomarkers of fiber and whole grain consumption and obesity and
chronic disease risk [71] . These nutritional factors may act to promote health by several
mechanisms, and fermentation in the gut is an important process where these components may
be synergistic or antagonistic.
Dietary Fiber: Current policies and recommendations promote optimal levels of fiber for
U.S. adults (38g/day and 25 g/day for men and women, respectively) [1]. Fiber is understood to
have complex chemical arrangements and health benefits in addition to its original role as
bulking agent. Fibers are mainly composed of plant constituents, such as polysaccharides and
lignin, that resist hydrolysis by the digestive enzymes present in man, and some fibers are
capable of being fermented by bacteria in the large intestine [72]. Resistant starch is a dietary
fiber. Fermentation of resistant starch stimulates the growth and maintenance of the gut
microflora [22]. The microflora produces many end products, including heat, gases, and short
chain fatty acids (SCFAs), and may stimulate gut hormone production. In this capacity, resistant
starch is unofficially considered to be a prebiotic, because it is a non–digestible food component
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that provides benefits to the host via microbial fermentation. Prebiotics are important to the
health of the gastrointestinal (GI) tract, providing the symbiotic link between host and the gut
ecosystem. This ecosystem, the microbiota, can respond to dietary intake and provide health
benefits as a “normobiosis.” In contrast, a “dysbiosis” is a landscape where potentially harmful
micro–organisms may populate the gut [73].
Dietary Fat: Dietary fat plays an important role in body health. It is a convenient and
economical way to store energy in the body, but has additional physiologically active roles. It
has been established that fat alone is not responsible for increasing adiposity, but consuming fat
in conjunction with a relatively unrestricted energy intake contributes to increased weight gain
[74]. Dietary fat has a complex role in the body and is useful for determining the roles of other
bioactive components in food to determine how gut health is affected. Diets that contain fiber–
rich carbohydrate and low levels of fat are both lower in calories and believed to be more
satiating. Lower energy from fat appears to be important in the prevention and treatment of
obesity. Still, many studies in models for humans tend to focus on consuming low (18–20% of
energy) and very high (60–70% of energy) dietary fat intake [57, 58], but neglect an intake
representative of the average American (~33% of energy).
In rodent models, studies have examined other levels of fat in the diet, improving the
characterization of dietary fat as it affects other bioactive components.

Charrier et al. (2013)

demonstrated high fat (HF, 42% of energy) diets partially attenuated resistant starch fermentation
in Sprague Dawley rats [9]. Zhou et al. (2009) demonstrated moderate fat (MF, 28% of energy)
diets were effective at reducing abdominal fat percentage (ABF%) as well as low fat (LF, 18% of
energy) diets when combined with resistant starch in C57bl/6J mice [10]. These studies showed
how dietary fat had different effects on rodent health, but human studies using diets containing
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fat at doses akin to average intake still need more exploration for their roles in fermentation and
chronic disease.
Whole Grains: Whole grains consist of three parts: the bran, the germ, and a starchy
endosperm [75]. For a food to be considered whole grain, the bran, germ, and endosperm must
be present in relative proportions found naturally in the kernel [35] . Present in the bran, are
dietary fiber and phytochemicals, chemicals derived from plants that include a large class of
compounds that represent thousands of possibly bioactive molecules. One of the dietary fibers
present in whole grains is resistant starch. The germ and endosperm contain other necessary
macro– and micronutrients.

Whole grains have been associated with reduced risk for

cardiovascular disease, type 2 diabetes [37, 38], cancers [39–41], and all–cause mortality [42,
43]. Despite the benefits derived from consumption and fermentation, whole grain intake has
remained less than one–third consumed while the recommendation is to make one–half of all
grains consumed [47]. However, more research is needed to elucidate the role of whole grains as
both a standalone component and how its mode of action is affected by other nutrients and
systems in the body.
Identifying rodent models that respond to these dietary treatments may prove valuable to
research on human health. It is important to understand how these bioactive components work in
isolation, but only as a prelude to understanding how they work with or against each other. The
purpose of this study was to determine if combinations of resistant starch, whole grains, and fat
can improve gut health and biometric phenotypic measures. The objectives were to determine if
moderate dietary fat consumption provided greater health effects than high dietary fat
consumption, and if a whole grain diet with increased resistant starch was more efficacious than
a non–whole grain resistant starch diet. In order to accomplish this, we designed a study to
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determine how these bioactive components acted individually and to examine the compatibility
of the components in regards to gut fermentation and biometric measures by determining
possible interaction in a factorial study.
3.2. Methods
The experimental design for this study was a three–way ANOVA (Figure 3.1) with the following
factors: (1) Resistant starch (RS) (Present or Absent), (2) Whole Grain (WG) (Present or
Absent), and (3) FAT (Moderate or High).

Figure 3.1. Experimental design. Study was designed as a three–way ANOVA. Each of
eight groups (n=12) contains a level of each factor: Resistant Starch, Whole Grain, FAT.
Levels for factors are Resistant Starch (Present or Absent), Whole Grain (Present or Absent)
and FAT (Moderate or High).
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Diets
Diet treatments were adapted from AIN–93M purified diets for rodents (Table 3.1) [76]. Diets
contained one major starch source as either an isolated starch product or as whole grain flour.
Starches and whole grain flours were analyzed by proximate analysis (Medallion Labs for
Ingredion Incorporated). Starches included: (1) AMIOCA® waxy corn starch, (2) HI–MAIZE®
resistant corn starch, (3) Waxy whole grain corn flour, or (4) HI–MAIZE® whole grain resistant
corn flour. Diets with resistant starch were calculated to contain 23% resistant starch by weight.
Diets with waxy whole grain starch were calculated to have 4.93% resistant starch, due to the
whole grain kernel containing a resistant starch component because of the whole grain matrix
when not overly processed. The whole grain resistant starch has both resistant starch type 1
(RS1) and resistant starch type 2 (RS2). The RS1 exists because the matrix of the whole grain
kernel in the flour prevents access of the amylase enzymes to the starch; and the RS2 exists
because of the granular structure of the high–amylose starch granules [77]. Thus, whole grain
resistant starch would have a combination of RS1 and RS2, presumably mostly RS2. The whole
grain control group was fed a diet that included a waxy whole grain flour product. This product
also comes from a natural corn variety, but this product has 100% amylopectin for its starch
component. Therefore, the waxy whole grain product has RS1, but no RS2. The amount of the
waxy whole grain product used in the study resulted in ~5% of the diet as RS1. Resistant starch
content was determined by Ingredion Incorporated using the modified Englyst Assay [78].
Assays for resistant starch do not distinguish between types of resistant starch.
Cellulose and AMIOCA® waxy corn starch were used to moderate the energy of each diet
so that all diets within moderate fat or high fat, respectively, were isocaloric. Moderate and high
fat diets were calculated to provide 3.75±0.01 kcal/g and 4.2± 0.07kcal/g respectively. Casein
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was the major source of protein for the diets. Casein present in the diet differs from the typical
140 g/kg found in AIN–93M diets because the starches contain small amounts and whole grain
corn flours do contain considerable amounts of protein. Corn oil and lard were used to provide
the major source of fat in the diets. Fats were calculated to provide ~30% of energy for MF and
~42% of energy for HF diets. Fats were chosen to represent a ratio of saturated and unsaturated
fats of

1 2

1 1

: for MF and 2 : 2 for HF. Corn oil was used instead of soybean oil (AIN–93M) to

3 3

better reflect fats present in the corn kernel used to derive the corn starches and corn flours used
and was adjusted by the amount of fat present in starches and whole grain flours. A small amount
of tert–Butylhydroquinone (TBHQ) was present in the corn oil as a preservative. Vitamins and
minerals were in accordance with the AIN–93M diets, except for choline bitartrate, which was
substituted with choline chloride.
Table 3.1. Diet composition.
1

CON
Ingredients
Waxy corn starch2
High–amylose
corn starch3
High–amylose
whole grain starch
Waxy whole
grain starch4
Sucrose
Casein5
Cellulose
Corn oil6
Lard6
Mineral mix
Vitamin mix
Choline chloride
(table cont’d.)

Grams
473.30

Moderate Fat
HAMRS
Grams
72.31

WWG
Grams
67.83

HMWG
Grams
143.74

0.00

524.00

0.00

0.00

0.00

0.00

0.00

520.00

0.00

0.00

500.00

0.00

100.00
136.00
115.00
85.00
42.50
35.00
10.00
2.80

100.00
133.12
0.00
79.87
42.50
35.00
10.00
2.80

100.00
99.42
78.00
64.05
42.50
35.00
10.00
2.80

100.00
80.56
24.00
41.00
42.50
35.00
10.00
2.80
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1

CON
Ingredients
L–Cystine
Total
Resistant Starch, %7
Total Energy, kcal

Grams
1.80
1000.00
0
3757
CON1

Moderate Fat
HAMRS
Grams
1.80
1000.00
23.37
3750
High Fat
HAMRS
Grams
0.00

WWG
Grams
1.80
1000.00
4.93
3761

HMWG
Grams
1.80
1000.00
23.45
3754

WWG
Grams
0.00

HMWG
Grams
77.85

Ingredients
Grams
2
Waxy corn starch
405.80
High–amylose
0.00
524.66
0.00
0.00
corn starch3
High–amylose
0.00
0.00
0.00
525.00
whole grain starch
Waxy whole
0.00
0.00
517.00
0.00
grain starch4
Sucrose
100.00
100.00
100.00
100.00
Casein5
136.75
133.70
98.74
80.58
Cellulose
110.00
0.00
56.91
10.00
Corn oil6
99.25
93.44
79.15
58.37
6
Lard
100.00
100.00
100.00
100.00
Mineral mix
35.00
35.00
35.00
35.00
Vitamin mix
10.00
10.00
10.00
10.00
Choline chloride
2.80
2.80
2.80
2.80
L–Cystine
1.80
1.80
1.80
1.80
Total
1000.00
1000.00
1000.00
1000.00
7
23.32
5.03
23.41
0
Resistant Starch, %
4136
4230
4209
4164
Total Energy, kcal
1
Diets include: CON = Amylopectin control corn starch containing no resistant starch diet;
HAMRS = Isolated high–amylose starch (HAMRS) corn starch diet; WWG = waxy whole grain
amylopectin control corn flour containing low resistant starch diet; HMWG = whole grain
HAMRS corn starch diet.
2
AMIOCA® corn starch containing 100% amylopectin starch that is digestible.
3
HI–MAIZE® resistant corn starch.
4
Waxy & high–amylose corn starches and whole grain flours were gifts from Ingredion
Incorporated (Bridgewater, NJ).
5
Casein was reduced in each diet based on the protein constituent in AMICOA® and HI–
MAIZE® corn starches and whole grain flours analyzed by proximate analysis performed by
Medallion Labs for Ingredion Incorporated, and differs from the AIN–93M standard 140 g/kg.
(table cont’d.)
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6

Corn oil was modified in each diet based on the fat content in AMICOA® and HI–MAIZE®
corn starches and whole grain flours analyzed by proximate analysis performed by Medallion
Labs (Minneapolis, MN) for Ingredion Incorporated (Bridgewater, NJ). Corn oil and lard were
calculated to adjust fat present in all diets to ~ 30% of energy for moderate fat, and ~42% of
energy for high fat. The aim was to have corn oil be ~20% and lard ~10% of the energy for the
moderate fat diets; and for high fat diets corn oil and lard each contributed ~21% of energy
each. These values differ from the AIN–93M standard 40 g/kg.
7
Diets with high amylose starch contain resistant starch type 2, but the whole grain flour with
high amylose has both resistant starches types 1 and 2. Diets with waxy whole grain flour
contain only resistant starch type 1. Resistant starch content of experimental starches was
determined by Ingredion Incorporated using modified Englyst assay [78].
Animals & Euthanasia
Ninety–six male Sprague Dawley rats were purchased from Envigo (Somerset, NJ) at six weeks
of age, and maintained on a chow diet during a one week quarantine. Rats were then stratified
randomly by body weight into eight groups (n=12, average 259±8.4 grams). Treatment groups
consisted of moderate fat (MF) and high fat (HF) diets prepared to contain each of the following
starch sources: (1) control starch with no whole grains or resistant starch [79], (2) whole grain
waxy corn flour [WWG], (3) isolated high–amylose maize (HAM) with high resistant starch
[HAMRS], and (4) WG HAM flour rich in resistant starch (WGRS) [HMWG].
Animals were housed in a locked facility in individual stainless steel hanging cages with
wire mesh bottoms to measure food spilled and prevent coprophagy. Housing environmental
conditions included a 12:12h light–dark cycle, 21–22°C ambient temperature with a 55% relative
humidity. Animals were allowed ad libitum access to food and water for six weeks. Food
intake, food spilled, and body weight were measured twice per week.
Rats were euthanized and exsanguinated by cardiac puncture after inhalation of
isoflurane anesthesia delivered by soaked cotton balls.

For each rat, blood samples were

collected with dipeptidyl peptidase IV inhibitor for additional analyses. The gastrointestinal (GI)
tract was removed from the base of the esophagus to the anus, separated into individual parts
(stomach, small intestine, cecum, and large intestine) and weighed full and empty. Subcutaneous
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inguinal fat and abdominal fat pads (epididymal, perirenal, and retroperitoneal) were collected
and weighed to determine percentage of abdominal fat (ABF%). Abdominal fat percent was
calculated as the abdominal fat pads divided by the body weight of the rat with the GI tract
contents weight removed (ABF =

Abdominal Fat Pads
* 100).
Body weight – Full GI + Empty GI

Cecal contents were

collected and divided into 0.5 g aliquots, and frozen in liquid N2 for measurement of pH and
short–chain fatty acids (SCFAs). Cells lining the ceca, inguinal and epididymal fat pads were
flash frozen in liquid N2 and stored at –80°C until later analysis. The protocol for this study was
approved by the Louisiana State University Institutional Animal Care and Use Committee,
protocol 13–088.
Blood measurements
Serum active glucagon–like peptide 1 (GLP–1, ALPCO, NH), and C–reactive protein (CRP),
tumor necrosis factor alpha (TNF–α), and interleukin–10 (IL–10, ThermoFisher, Waltham, MA)
levels were measured with enzyme–linked immunosorbent assay (ELISA) kits.
Cecal contents pH and short–chain fatty acids analysis
Cecal contents were thawed and 0.5 g of sample was homogenized with 5 ml of distilled
water for pH measurements. Wet and dry weights were measured for each sample. Each wet
sample was then acidified with 1 ml 25% (wt/wt) solution metaphosphoric acid containing a 2
g/L 2–ethyl–butyric acid internal standard. Solids were separated by centrifugation at 8,000 X g
for 10 minutes and filtered through a Millipore filter (MILX HA 33 mm, 0.45 μm MCE STRL;
Fisher SLHA 033SS). The filtered liquid was transferred to a gas chromatograph (GC)
autosampler vial.

SCFAs were analyzed by gas–liquid chromatography for quantitative

determination. Detailed methods for quantification of SCFAs via GC have been described in
previous publications from our lab [9].
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Quantitative real–time PCR (qPCR)
RNA was extracted from cecal cells and inguinal adipose tissue using the RNeasy Mini
Kit and RNeasy Lipid Tissue Mini Kit, respectively (Qiagen, Valencia, CA). Samples with a
poor 260/230 absorption spectra ratio (lower than 1.8) were purified using GeneJet RNA
Cleanup and Concentration Micro Kits (ThermoFisher Scientific, Waltham, MA). TaqMan®
Gene Expression Assays (ThermoFisher, Waltham, MA) were used to measure intestinal
gluconeogenesis

(IGN)

(glucose–6–phosphatase

(G6pc),

pyruvate

carboxylase

(PC),

phosphoenolpyruvate carboxykinase 1 (PCK1)), colonic barrier and goblet cell function (UDP–
galactose–4–epimerase (GALE), monocarboxylate transporter member 1 (MCT1),

mucin 1

(MUC1)), and response to oxidative stress (adrenomedullin (ADM)) in cecal cells. TaqMan®
Gene Expression Assays (ThermoFisher, Waltham, MA) were used to measure pro–
inflammatory status (IL–6, TNF–α), anti–inflammatory status (IL–10), and bacterial
manipulation (angiopoietin–like 4 (ANGPTL4), leptin (LEP), solute carrier family 25 member 25
(SLC25A25)) in inguinal adipose tissue. Cecal cell and inguinal adipose gene expression were
normalized using cyclophilin–F (PPIF) and 18S rRNA, respectively.
DNA extraction and Next Generation DNA Sequencing and Bioinformatics
DNA was extracted by Louisiana State University Health Sciences Center. Purified
DNA was sequenced using a MiSeq instrument after massive parallel PCR amplification was
used to incorporate primers with barcodes to identify individual samples. Relative abundance of
bacteria was determined using Quantitative Insights Into Microbial Ecology (QIIME) 1.9 and
DaDa2 package pipeline assembly to assign operational taxonomic units (OTU) for use in
determination of alpha– and beta–diversity.
Statistical Analysis
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Statistical analysis was performed using Statistical Analysis Software SAS® version 9.4
(SAS Institute Inc., Cary, NC, USA). A 2x2x2 factorial analysis was performed using the
MIXED procedure. The three factors were resistant starch (RS, Present or Absent), whole grain
(WG, Present or Absent), and fat (FAT, High or Moderate). The model used the three factors as
fixed effects, and did not use random effects. The linear model tested was:
Y = β0 + β1X1 + β2X2 + β3X3 + β12X1X2 + β13X1X3 + β23X2X3 + β123X1X2X3 + ϵ
where {

𝑅𝑆
1 𝑊𝐺
1
𝐻𝐹
1
X1 = { , {
X2 = { , and {
X3 = { . Denominator degrees of freedom for
𝑁𝑅𝑆
0 𝑁𝑊𝐺
0
𝑀𝐹
0

fixed effects used the Kenward–Roger approximation. An F–test with p<0.05 was considered
statistically significant for interactions and main effects. Benjamini–Hochberg false discovery
rate (B–H FDR) was then used to screen dependent variable F–test p–values for interactions and
main effects [80]. The B–H FDR procedure consists of ranking (indexing) the raw p–values
from lowest to highest and then comparing each to the critical value (CV), which is determined
by the formula “I/M*Q”. “I” is the rank number, “M” is the total number of dependent variables,
and “Q” is the chosen false discovery rate. The largest p–value less than the CV and all p–values
smaller pass the FDR test. A Q = 0.05 was chosen as the false discovery rate.
If a dependent variable passed the FDR test, a statistical slice on two 2–way interactions
(RS*WG, RS*Fat) was performed for 3–way interactions, and a statistical slice on main effects
was performed for 2–way interactions. Main effects used only the F–statistic and subsequent p–
value. The described slices return eight pairwise comparisons for 3–way interactions and four
pairwise comparisons for 2–way interactions. To correct for multiple comparisons, a Bonferroni
adjustment to the significance level was performed. A Bonferroni corrected p–value < 0.00625
(α=0.05/8) was considered statistically significant for pairwise comparisons within 3–way
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interactions, and a corrected p–value < 0.0125 (α=0.05/4) was considered statistically significant
for pairwise comparisons within 2–way interactions. Data are expressed as means ± pooled SE.
Homogeneity of variance and influence diagnostics were tested within the MIXED
procedure, while tests for normality were conducted using the UNIVARIATE procedure. A null
model likelihood ratio test (χ2) was performed to determine if variance was homogeneous or
heterogeneous.

If variance was homogeneous, then normality testing of residual values used

pooled group residuals. Heterogeneous variance proceeded with variance calculated for each
group. Influential outliers, tested using studentized residuals and leverage, were removed only if
their presence prevented normal distribution for statistical analysis. Influences on parameter
estimates were examined using Cook’s D. Data from dependent variables that violated the
normality assumption were transformed to log10. Following log10 transformation, normality and
homogeneity of variance testing were reapplied. Data violating the normality assumption after
transformation was considered not normally distributed and reverted to raw data. The following
variables were transformed due to non–normal distribution (p<0.05 for Shapiro–Wilk test):
weight of empty ceca (ECW); each of the three major SCFA in the ceca. Transformed dependent
variables were back–transformed by taking the antilog. When no significant interactions were
observed, only the main effect was reported. If an independent variable was dominant (much
lower p–value) as a main effect, this was noted even if an interaction(s) was (were) significant.
3.3. Results
3.3.1 Biometric Analysis
All rats fed whole grain resistant starch, one rat fed isolated resistant starch with high fat,
and two rats fed isolated resistant starch with moderate fat diet had loose stools during week 1 of
the six week study. Rats fed the control diets (NRS) had no loose stools throughout the study.
As the study continued, several of the resistant starch fed rats intermittently had soft stools.
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During week 6, one whole grain resistant starch rat fed moderate fat diet and one isolated
resistant starch rat fed high fat diet had loose stools. Since the loose stool occurrences in week 1
occurred for all whole grain resistant starch fed rats and three isolated resistant starch fed rats,
the greater reduction in ABF% for the isolated resistant starch moderate fat diet group was likely
not the result of loose stools. If loose stools had a significant effect on ABF%, the whole grain
resistant starch fed rats would have greater reductions in ABF% than the high isolated resistant
starch fed rats. During intervals of loose stools, affected rats continued to gain weight and did
not appear dehydrated. No RS groups (CON, WWG) experienced no loose stools. Intermittent
stool softness did not persist noticeably as the study progressed.
Data were examined and influential outlier measurements were removed to achieve a
normal distribution with or without log10 transformation of the data.

One data point was

removed for ABF% (WWG HF: 4.459), µmol propionate produced in total amount of cecal
contents (HAMRS MF: 0.0127), and µmol butyrate produced (HAMRS MF: 0.014). Four
influential data points were removed for cecal contents pH (CON HF: 6.57; HAMRS HF: 8.23;
HMWG MF: 6.12, 7.78). Six data points were removed for active GLP–1 (CON HF: 2.053;
HAMRS HF: 2.442; HAMRS MF: 1.971, 3.218; HMWG HF: 1.823; HMWG MF: 2.831).
Following the PROC MIXED factorial analyses, no 3–way interactions were found to be
significant. However, the empty cecum weight (ECW, F1,87 = 3.85, p > .05) was approaching
significance at p=0.0529 and warranted further examination looking into the components within.
All dependent variables were also ranked by raw p–values below in Table 3.2 using the B–H
FDR test. The lowest critical value CV for the B–H FDR test was 0.0045 and no p–values were
less than the CV.
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Table 3.2. Biometric analysis F–test p–values sorted by B–H FDR1.
RS*WG*FAT
RS*WG
Variables2

p

Variables

p
<0.0001†
<0.0001†
<0.0001†
<0.0001†
0.0075†
0.3630
0.6537
0.6619
0.6986
0.8269
0.9872

Empty Cecum Wt. (g)
Cecal contents pH
Acetate (µmol)
Propionate (µmol)
Food Intake (g)
Energy intake (kcal)
Abdominal body fat %3
Inguinal Fat (g)
Emboweled body weight (g)
Butyrate (µmol)
Active GLP–1 (pM)

0.0529
0.2046
0.3025
0.3923
0.4147
0.4346
0.4948
0.6225
0.8439
0.9177
0.9189

Acetate (µmol)
Propionate (µmol)
Cecal contents pH
Empty Cecum Wt. (g)
Butyrate (µmol)
Active GLP–1 (pM)
Inguinal Fat (g)
Food Intake (g)
Energy intake (kcal)
Abdominal body fat %3
Emboweled body weight (g)

Most relevant CV4

0.0045

Most relevant CV4

0.0227

RS*FAT
Variables
Empty Cecum Wt. (g)
Acetate (µmol)
Propionate (µmol)
Energy intake (kcal)
Food Intake (g)
Butyrate (µmol)
Abdominal body fat %3
Cecal contents pH
Emboweled body weight (g)
Inguinal Fat (g)
Active GLP–1 (pM)

p
0.1386
0.1523
0.3231
0.3713
0.4017
0.4324
0.4355
0.8086
0.8426
0.8662
0.9506

WG*FAT
Variables
Propionate (µmol)
Acetate (µmol)
Emboweled body weight (g)
Inguinal Fat (g)
Butyrate (µmol)
Empty Cecum Wt. (g)
Food Intake (g)
Cecal contents pH
Energy intake (kcal)
Abdominal body fat %3
Active GLP–1 (pM)

p
0.0050†
0.0155†
0.0322†
0.1727
0.2169
0.2395
0.3314
0.3331
0.3756
0.4051
0.5888

Most relevant CV4

0.0045

Most relevant CV4

0.0045

RS
Variables
Active GLP–1 (pM)
Empty Cecum Wt. (g)
Acetate (µmol)
Propionate (µmol)
Butyrate (µmol)
Cecal contents pH
Abdominal body fat %3
Inguinal Fat (g)
Emboweled body weight (g)
(table cont’d.)

WG
p
<0.0001†
<0.0001†
<0.0001†
<0.0001†
<0.0001†
<0.0001†
<0.0001†
<0.0001†
0.0012†

Variables
Butyrate (µmol)
Cecal contents pH
Acetate (µmol)
Active GLP–1 (pM)
Food Intake (g)
Abdominal body fat %3
Energy intake (kcal)
Emboweled body weight (g)
Propionate (µmol)
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p
<0.0001†
0.0017†
0.0066†
0.0775
0.1814
0.1961
0.2052
0.3261
0.4845

RS

WG

Variables
Energy intake (kcal)
Food Intake (g)

p
0.2117
0.2227

Variables
Empty Cecum Wt. (g)
Inguinal Fat (g)

p
0.8290
0.8402

Most relevant CV4

0.0409

Most relevant CV4

0.0136

Fat
Variables
Food Intake (g)
Energy intake (kcal)
Abdominal body fat %3
Empty Cecum Wt. (g)
Inguinal Fat (g)
Acetate (µmol)
Butyrate (µmol)
Active GLP–1 (pM)
Cecal contents pH
Emboweled body weight (g)
Propionate (µmol)

B–H Critical Values (Q = 0.05)
p
<0.0001†
0.0013†
0.0064†
0.0147†
0.0613
0.1431
0.2472
0.5896
0.6438
0.6710
0.9312

Rank
1
2
3
4
5
6
7
8
9
10
11

CV
0.0045
0.0091
0.0136
0.0182
0.0227
0.0273
0.0318
0.0364
0.0409
0.0455
0.0500

Most relevant CV4
0.0182
1
Data are shown based on factors, resistant starch (RS, Present or Absent), whole grains (WG,
Present or Absent) and fat (FAT, High or Moderate).
2
An ANOVA F–test F<0.05 indicates a significant measurement with † superscript denoting
significant difference.
3
4

ABF%:

Abdominal Fat Pads
Body weight – Full GI + Empty GI

∗ 100

Most relevant CV is determined from the greatest significant p–value of dependent variables
(ranked lowest to highest) that is less than the CV at each rank, given I/M*Q. “I” is the rank
number, “M” is the total number of dependent variables (11), and “Q” is the chosen false
discovery rate (0.05).
3.3.1.1 Three–way Interactions
Resistant Starch * Whole Grain * FAT interaction
Empty cecum weight (ECW) approached significance (p=0.0529) for the interaction
among the three factors (Figure 3.2). Increased empty cecum weight is a marker of increased
fermentation as described in the introduction section. Thus, these findings suggest a consistent
fermentation of whole grains in both moderate and high fat diets in the presence of high resistant
starch as RS2, but resistant starch without whole grains fermented best on a moderate fat diet as
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compared to a high fat diet and better than whole grain on either a moderate or high fat diet.
Data for all three–way interactions are also presented as means with pooled SEM in Table 3.3.

Empty Cecum Weight (g)

2.5
2
1.5
MF
1

HF

0.5
0
NWG

WG

NWG

WG

NRS

RS

Figure 3.2. Three–way interaction of RS*WG*FAT on ECW. The interaction for RS*WG*FAT
(p=0.0529) is presented. Groupings include: RS = resistant to digestion starch type 2 that has
high amylose, NRS = no resistant to digestion starch type 2, WG = Whole grain present, NWG =
whole grain absent, MF = moderate fat and HF = high fat. Data are shown as three factors,
resistant starch (RS, Present or Absent) and whole grain (WG, Present or Absent) with the third
factor fat (FAT, High or Moderate). Data are expressed in their original form as antilog means ±
standard error.
Table 3.3. Three–way interactions for fermentation variables1.
RS * WG * Fat Interaction
RS
RS
NRS
NRS
WG
NWG
WG
NWG
Pooled
MF
MF
MF
MF
SEM
Variables
(HF)
(HF)
(HF)
(HF)
780.41
769.84
769.72
761.19
Food Intake (g)3
13.8399
(720.74)
(713.29)
(737.50)
(737.60)
2934.36
2894.60
2995.67
2862.07
Energy intake (kcal)3
55.7115
(3027.11) (2995.80) (3097.52) (3097.94)
Active Glucagon–like
1.2696
1.3646
0.9234
0.9332
0.0552
peptide 1 (pM)
(1.2765)
(1.4083)
(0.9165)
(0.9803)
6.9480
6.1350
8.0133
8.2900
Cecal contents pH
0.0830
(6.7925)
(6.2627)
(7.9882)
(8.2264)
1.0936
2.1981
0.5441
0.4637
Empty Cecum Wt. (g)
0.0490
(1.6118)
(1.6248)
(0.5164)
(0.4168)
(table cont’d.)
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p–value
(F)2
0.4147
0.4346
0.9189
0.2046
0.0529

RS * WG * Fat Interaction
RS
RS
NRS
NRS
WG
NWG
WG
NWG
Pooled p–value
MF
MF
MF
MF
SEM
(F)2
Variables
(HF)
(HF)
(HF)
(HF)
1.0936
2.1981
0.5441
0.4637
Empty Cecum Wt. (g)
0.0490 0.0529
(1.6118)
(1.6248)
(0.5164)
(0.4168)
385.21
588.44
112.49
71.04
Acetate (µmol)
21.76
0.2998
(398.38)
(406.82)
(121.90)
(65.30)
45.21
89.85
16.67
13.71
Propionate (µmol)
4.48
0.3923
(62.14)
(73.94)
(17.81)
(11.08)
96.69
78.92
29.15
16.26
Butyrate (µmol)
5.40
0.9188
(91.18)
(63.12)
(31.27)
(14.36)
2.0298
1.9560
2.4533
2.4533
Abdominal body fat %4
0.1002 0.8416
(2.2008)
(2.1031)
(2.6968)
(2.6159)
2.9515
2.9902
3.6132
3.9715
Inguinal Fat (g)
0.2358 0.6225
(3.3932)
(3.1336)
(4.2792)
(4.0048)
379.98
384.73
396.24
403.06
EBW (g)
6.8844 0.8439
(392.66)
(378.14)
(408.90)
(392.61)
1
Data are shown as full or collapsed interactions based on significant factors, resistant starch
(RS, Present or Absent), whole grain (WG, Present or Absent), and fat (FAT, High or Moderate).
2
An ANOVA F–test p<0.05 indicates a significant measurement.
3
Total food and energy intakes over the total study of 6 weeks.
Abdominal Fat Pads
4
Abdominal body fat %:
∗ 100
Body weight – Full GI + Empty GI
3.3.1.2 Two–way Interactions
Significant differences for several dependent variables were observed for two of the two–
way interactions RS*WG and WG*FAT. The results are as follows: RS*WG – SCFAs acetate
(F1,63 = 44.96, p < .0001), propionate (F1,57 = 31.87, p < .0001), and butyrate (F1,55 = 7.33, p <
.05), ECW (F1,87 = 22.62, p < .0001), and cecal contents pH (F1,57 = 54.89, p < .0001), and
WG*FAT – SCFAs acetate (F1,63 = 6.20, p < .05), propionate (F1,57 = 8.53, p < .01), and EBW
(F1,88 = 4.74, p < .05). The RS*WG interaction was further analyzed using a statistical slice on
RS and WG factors, while the WG*FAT interaction was sliced on the WG and FAT factors
(Table 3.4). Test of slices were conducted, and adjusted using a Bonferroni corrected alpha level
of 0.0125 per test (0.05/4), i.e. four post hoc comparisons were used for the dependent variables
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Table 3.4. Two–way interactions test of effect slices for fermentation variables1,2.
RS * WG Interaction
RS
WG
NRS
RS
WG
NWG
WG vs. NWG WG vs. NWG
RS vs. NRS
RS vs. NRS
Variables
†
†
†
Acetate (µmol)
<0.0001
0.0072
<0.0001
<0.0001†
Propionate (µmol)
<0.0001†
0.0012†
<0.0001†
<0.0001†
†
†
†
Butyrate (µmol)
<0.0001
0.0070
<0.0001
<0.0001†
Cecal contents pH
<0.0001†
<0.0001†
<0.0001†
<0.0001†
†
†
†
Empty Cecum Wt. (g)
0.0020
0.0007
<0.0001
<0.0001†
WG * FAT Interaction
WG
FAT
NWG
WG
HF
MF
Variables
HF vs. MF
HF vs. MF
WG vs. NWG WG vs. NWG
Acetate (µmol)
0.0062†
0.4872
0.0004†
0.8255
Propionate (µmol)
0.0460
0.0505
0.1390
0.0136
Emboweled body weight (g)
0.2192
0.0691
0.0278
0.4028
1
Data are shown as full or collapsed interactions based on significant factors, resistant starch
(RS, Present or Absent), whole grain (WG, Present [WG] or Absent [NWG]), and fat (FAT,
High [HF] or Moderate [MF]).
2
After Bonferroni correction, an adjusted ANOVA F–test p<0.0125 indicates a significant
measurement.
that had a significant p–value for ANOVA F and also passed the B–H FDR test for the two–way
interactions. There were no significant two–way interactions for RS*FAT and no dependent
variables demonstrated a p–value for ANOVA F approaching significance for this interaction.
Differences observed in RS and FAT on several dependent variables are independent of the other
factor. Data for two–way interactions are presented as means with pooled SEM in Table 3.5.
Table 3.5. Descriptive statistics for two–way interactions for fermentation variables1.
RS * WG Interaction
RS
RS
NRS
NRS
Pooled
Variables
WG
NWG
WG
NWG
SEM
Food Intake (g)3
750.58
741.56
767.11
749.40
9.7863
Energy intake (kcal)3
2980.73 2945.20 3046.59 2980.00 39.3940
Active Glucagon–like
1.2730
1.3864
0.9200
0.9568
0.0390
peptide 1 (pM)
Cecal contents pH
6.8702a
6.1989b 8.0008c
8.2582d
0.0311
a
b
c
d
Empty Cecum Wt. (g)
1.6181
1.8867
0.5265
0.4276
0.0286
(table cont’d.)
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p–value
(F)2
0.6619
0.6986
0.3630
<0.0001
<0.0001

Variables
Acetate (µmol)
Propionate (µmol)
Butyrate (µmol)
Abdominal body fat %4
Inguinal Fat (g)
Emboweled body weight (g)

Variables
Food Intake (g)3
Energy intake (kcal)3
Active Glucagon–like
peptide 1 (pM)
Cecal contents pH
Empty Cecum Wt. (g)
Acetate (µmol)
Propionate (µmol)
Butyrate (µmol)
Abdominal body fat %4
Inguinal Fat (g)
Emboweled body weight (g)

Pooled
SEM
15.26
3.21
3.81
0.0709
0.1667
4.8680

p–value
(F)2
<0.0001
<0.0001
0.0090
0.7504
0.6537
0.9872

RS
MF
775.13
2914.48

RS * WG Interaction
NRS
NRS
WG
NWG
117.08c
68.11d
17.23c
12.33d
30.19b
15.28d
2.5751
2.5346
3.9462
3.9882
402.57
397.84
RS * FAT Interaction
RS
NRS
NRS
HF
MF
HF
717.01
778.95
737.55
3011.45 2928.87 3097.73

Pooled
SEM
9.7863
39.3940

p–value
(F) 2
0.4017
0.3713

1.3171

1.3424

0.0390

0.9506

6.5415
1.8578
476.10
63.74
87.36
1.9929
2.9709
382.35

6.5276
1.6429
402.53
67.80
75.86
2.1520
3.2634
385.40

0.0587
0.0286
15.12
3.15
3.75
0.0709
0.1667
4.8680

0.8086
0.1380
0.1505
0.3231
0.4389
0.7577
0.8662
0.8426

RS
WG
391.74a
53.00a
93.89a
2.1153
3.1723
386.32

RS
NWG
489.22b
81.51b
70.58a
2.0295
3.0619
381.43

0.9283

0.9484

8.1517
8.1073
0.4985
0.4834
89.39
89.23
15.12
14.05
21.77
21.19
2.4533
2.6564
3.7923
4.1420
399.65
400.75
WG * FAT Interaction
WG
NWG
NWG
HF
MF
HF
729.12
765.51
725.44
3062.31 2878.33 3046.87

WG
Pooled
p–value
Variables
MF
SEM
(F) 2
3
Food Intake (g)
788.57
9.9137
0.3314
Energy intake (kcal)3
2965.02
39.9722
0.3756
Active Glucagon–like
1.0965
1.0965
1.1489
1.1943
0.0417
0.5888
peptide 1 (pM)
Cecal contents pH
7.4807
7.3903
7.2125
7.2445
0.0313
0.3331
Empty Cecum Wt. (g)
0.9418
0.9046
0.9835
0.8779
0.0286
0.2388
Acetate (µmol)
208.16a
220.34a
204.46b 162.97a
11.43
0.0155
a
ab
b
a
Propionate (µmol)
27.45
33.27
35.10
28.26
2.07
0.0050
Butyrate (µmol)
53.09
53.39
35.83
30.10
3.11
0.2240
4
Abdominal body fat %
2.2416
2.4488
2.2047
2.3595
0.0709
0.7132
Inguinal Fat (g)
3.2823
3.8362
3.4809
3.5692
0.1692
0.1727
ab
a
ab
b
Emboweled body weight (g) 388.11
400.78
393.90
385.38
4.8680
0.0322
1
Data are shown as full or collapsed interactions based on significant factors, resistant starch
(RS, Present or Absent), whole grain (WG, Present or Absent), and fat (FAT, High or Moderate).
2
An ANOVA F–test p<0.05 indicates a significant measurement.
3
Total food and energy intakes over the total study of 6 weeks.
Abdominal Fat Pads
4
Abdominal body fat %:
∗ 100
Body weight – Full GI + Empty GI
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Cecal Contents pH (α<0.0125)
The presence of resistant starch with WG (6.87±0.08) resulted in a significantly greater
cecal contents pH than when isolated resistant starch (6.20±0.08) was in the diet without whole
grains (Figure 3.3). In the absence of resistant starch, the presence of whole grains (8.00±0.04)
significantly reduced pH compared with NWG with NRS (8.26±0.04).

The other two

comparisons between RS and NRS with either WG (6.87±0.08 vs. 8.00±0.04) or NWG
(6.20±0.08 vs. 8.26±0.04) were also significant. The lower cecal content pH values in rats fed
resistant starch versus no resistant starch indicate increased fermentation in the cecum. In the
waxy (no amylose starch) whole grain control flour groups (NRSWG) there was a low amount of
RS (4.93 of diet) only as RS1 as part of the whole grain matrix, but the NRS NWG groups (HF
and MF) had essentially no resistant starch. The presence of a small amount of RS1 resulted in
some degree of fermentation.
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Figure 3.3. Two–way interaction of RS*WG for pH of cecal contents. Grouping includes: RS =
resistant to digestion starch type 2 that has high amylose, NRS = no resistant to digestion starch
type 2, WG = whole grain flour NWG = no whole grain flour. Data are shown collapsed on two
factors, resistant starch (RS, Present or Absent) and whole grain (WG, Present or Absent). Data
are expressed in their original form as means ± standard error. Different letters above each bar in
the left figure denote significant differences at p<0.0125. The line graph figure on the right has
the same data and is included for additional visualization.
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Empty Cecum Weight (α<0.0125)
Increased ECW is an indicator that greater fermentation has occurred in the cecum
(Figure 3.4). The presence of resistant starch without whole grains resulted in a significantly
greater ECW (1.88 g±0.06) and fermentation than resistant starch with whole grains (1.62
g±0.05). In the absence of resistant starch, whole grains had significantly greater fermentation
(0.53 g±0.02) than without whole grains (0.46 g±0.01). Comparing the resistant starch groups to
appropriate whole grain or non–whole grain controls resulted in significant differences.
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Figure 3.4. Two–way interaction of RS*WG for ECW. Grouping includes: RS = resistant to
digestion starch type 2 that has high amylose, NRS = no resistant to digestion starch type 2, WG
= whole grain flour NWG = no whole grain flour. Data are shown collapsed on two factors,
resistant starch (RS, Present or Absent) and whole grain (WG, Present or Absent). Data are
expressed in their original form as means ± standard error. Different letters above each bar in the
left figure denote significant differences at p<0.0125. The line graph figure on the right has the
same data and is included for additional visualization.
Short–chain fatty acids acetate, propionate, and butyrate (α<0.0125)
RS*WG: The presence of resistant starch without whole grains had greater production of
acetate (489.22 µmol±27.94) than whole grain resistant starch (391.74 µmol±22.37), but was not
statistically significantly at p>0.0125 (p<0.0295). In the absence of resistant starch, whole grain
had significantly greater acetate production (117.08 µmol±6.84) than without whole grains
(68.11 µmol±3.89). Acetate production was significantly greater when examining the
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comparisons of whole grain resistant starch (391.74 µmol±22.37) to whole grain non–resistant
starch (117.08 µmol±6.84), and the presence of non–whole grain resistant starch (489.22
µmol±27.94) to the non–whole grain no resistant starch (68.11 µmol±3.89) group (Figure 3.5A).
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Figure 3.5. Two–way interactions of A. RS*WG and B. WG*FAT on µmol acetate produced.
Grouping includes: RS = resistant to digestion starch type 2 that has high amylose, NRS = no
resistant to digestion starch type 2, WG = whole grain flour, NWG = no whole grain flour, MF=
moderate fat, and HF = high fat. Data are shown collapsed on two factors, resistant starch (RS,
Present or Absent) and whole grain (WG, Present or Absent). Data are expressed in their
original form as antilog means ± standard error. Different letters above each bar denote
significant differences at p<0.0125. The line graph figures on the right have the same data and
are included for additional visualization.
WG*FAT: In the presence of whole grains, there was no significant difference between
MF (208.16 µmol±11.89) and HF (220.34 µmol±12.87) for µmol of acetate produced. However,
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in the absence of whole grain, µmol acetate produced was significantly greater with MF diets
(204.46 µmol±11.68) than HF diets (162.97 µmol±9.31). Upon examining MF diets, there was
no difference between whole grain presence and absence. However, the in HF diets, presence of
whole grains HF (220.34 µmol±12.87) was significantly greater than without whole grains
(162.97 µmol±9.31) (Figure 3.5B).
RS*WG: The presence of resistant starch without whole grain had significantly greater
production of propionate (81.51 µmol±7.08) than with whole grains (53.00 µmol±4.64) (Figure
3.6A). In the absence of resistant starch, whole grain had significantly greater propionate
production (17.23 µmol±0.58) than without whole grains (12.33 µmol±0.56). Propionate
production with whole grains present was significantly increased with resistant starch (53.00
µmol±4.64) than without resistant starch (17.23 µmol±0.58). The comparison of resistant starch
(81.51 µmol±7.08) and non–resistant starch with no whole grains (12.33 µmol±0.56) resulted in
significantly greater propionate production for the isolated resistant starch group.
WG*FAT: There were no significant differences for propionate production at p<0.0125.
However, for MF diets, the absence of whole grain led to numerically higher production of
production of propionate, while for HF diets, whole grain presence led to higher production to
result in the significant interaction (Figure 3.6B).
RS*WG: The presence of resistant starch without whole grains (70.58 µmol±5.21) was
significantly different for production of butyrate compared to whole grain resistant starch (93.89
µmol±6.78) (Figure 3.7). In the absence of resistant starch, whole grains had significantly
greater butyrate production (30.19 µmol±2.18) than without whole grains (15.28 µmol±1.08).
This dependent variable was unique in that whole grains had greater values with both presence
and absences of resistant starch. Butyrate production with whole grains present was significantly
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increased with resistant starch (93.89 µmol±6.78) than without resistant starch (30.19
µmol±2.18); and in the absence of whole grains, resistant starch had significantly greater
production of butyrate (70.58 µmol±5.21) than in the absence of resistant starch (15.28
µmol±1.08).
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Figure 3.6. Two–way interactions of A. RS*WG and B. WG*FAT on µmol propionate
produced. Grouping includes: RS = resistant to digestion starch type 2 that has high amylose,
NRS = no resistant to digestion starch type 2, WG = whole grain flour, NWG = no whole grain
flour, MF= moderate fat, and HF = high fat. Data are shown collapsed on two factors, resistant
starch (RS, Present or Absent) and whole grain (WG, Present or Absent). Data are expressed in
their original form as antilog means ± standard error. Different letters above each bar denote
significant differences at p<0.0125. The line graph figures on the right have the same data and
are included for additional visualization.
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Figure 3.7. Two–way interaction of RS*WG on µmol butyrate produced. Grouping includes: RS
= resistant to digestion starch type 2 that has high amylose, NRS = no resistant to digestion
starch type 2, WG = whole grain flour NWG = no whole grain flour. Data are shown collapsed
on two factors, resistant starch (RS, Present or Absent) and whole grain (WG, Present or
Absent). Data are expressed in their original form as antilog means ± standard error. Different
letters above each bar in the left figure denote significant differences at p<0.0125. The line
graph figure on the right has the same data and is included for additional visualization.
Emboweled Body weight
The WG*FAT two–way interaction for EBW was statistically significant but within the
interaction, no measurement met significance at p<0.0125.
3.3.1.3 Main Effects
Descriptive statistics for main effects for the factors RS, WG, and FAT are shown in Table 3.6.
Food and energy intake, fermentation–associated factors, and physiological variables were
examined. Data for all main effects are presented as means with pooled SEM.
Table 3.6. Descriptive statistics about response to dietary factors – Main Effects1.
Resistant Starch
Variables

Present

Absent

Pooled SEM

Food Intake (g)
Energy intake (kcal)
Active Glucagon–like
peptide 1 (pM)
Cecal contents pH
(table cont’d.)

746.07
2962.97

758.25
3013.3

6.920
27.8558

p–value
(F)2
0.2227
0.2117

1.3297a

0.9384b

0.0276

<0.0001

6.5346a

8.1295b

0.0415

<0.0001
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Resistant Starch
Present

Absent

Empty Cecum Wt. (g)
Acetate (µmol)
Propionate (µmol)
Butyrate (µmol)
Abdominal body fat %3
Inguinal Fat (g)
Emboweled body weight (g)

1.7470a
437.72a
65.74a
81.41a
2.0724a
3.1171a
383.88a

0.4909b
89.31b
14.57b
21.48b
2.5548b
3.9672b
400.20b
Whole Grains

Variables

Present

Absent

Pooled SEM

Food Intake (g)
Energy intake (kcal)
Active Glucagon–like
peptide 1 (pM)
Cecal contents pH
Empty Cecum Wt. (g)
Acetate (µmol)
Propionate (µmol)
Butyrate (µmol)
Abdominal body fat %3
Inguinal Fat (g)
Emboweled body weight (g)

758.85
3013.66

745.48
2962.6

7.0101
28.2646

p–value
(F)2
0.1814
0.2052

1.0965

1.1716

0.0295

0.0775

0.0443
0.0202
7.74
1.48
2.25
0.0502
0.1196
3.4422

0.0017
0.8288
0.0067
0.4845
<0.0001
0.3796
0.8402
0.3262

7.4355a
0.9230
214.19a
30.22
53.24a
2.3452
3.5593
394.44

7.2285b
0.9292
182.56b
31.70
32.84b
2.2821
3.525
389.64
FAT
High
727.28b
3054.59b

Pooled SEM

p–value
(F)2
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
0.0012

Variables

0.0224
12.05
2.23
2.97
0.0502
0.1180
3.4372

Variables
Moderate
Pooled SEM p–value (F)
a
Food Intake (g)
777.04
7.0101
<0.0001
Energy intake (kcal)
2921.68a
28.2646
0.0013
Active Glucagon–like
1.1227
1.1454
0.0295
0.5896
peptide 1 (pM)
Cecal contents pH
7.3466
7.3174
0.0443
0.6438
Empty Cecum Wt. (g)
0.9624a
0.8911b
0.0202
0.0145
Acetate (µmol)
206.30
189.50
7.97
0.1414
Propionate (µmol)
31.04
30.86
1.48
0.9312
Butyrate (µmol)
43.61
40.10
2.14
0.2543
3
a
b
Abdominal body fat %
2.2231
2.4042
0.0500
0.0126
Inguinal Fat (g)
3.3816
3.7027
0.1196
0.0613
Emboweled body weight (g)
391.00
393.08
3.4422
0.6711
1
Data are shown based on factors, resistant starch (RS, Present or Absent), whole grains (WG,
Present or Absent) and fat (FAT, High or Moderate).
2
An ANOVA F–test p<0.05 indicates a significant measurement. Means with different letters
attached to numbers denote significant differences between groups (p<0.05).
3

ABF%:

Abdominal Fat Pads
Body weight – Full GI + Empty GI

∗ 100
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Resistant Starch
While food and energy intake were not significantly different between the two RS
groups, other variables differed.

Rats fed diets high in RS vs. NRS demonstrated increased

serum active GLP–1, ECW, µmoles of SCFA produced, and decreased cecal contents pH,
ABF%, inguinal fat, and EBW.

Serum active GLP–1, ABF% and inguinal fat dependent

variables were only significant as the main effect of RS (Figures 3.8A–C).

However, all

significant RS main effects are shown because RS demonstrated a dominant role in all dependent
variables that also had interaction effects. Empty cecum weight and µmoles SCFAs produced
are two of several indicators of increased fermentation in the gut of rodents. These significant
effects were evident when levels of FAT and WG were collapsed into high RS and NRS.
Whole Grain
Rats fed WG had increased cecal contents pH, acetate, and butyrate production. Significant
effects were evident when levels of RS and FAT were collapsed into WG presence and absence.
These main effects are part of interaction effects presented prior.
Fat
Three dependent variables that had observed differences between rats fed diets with high
and moderate levels of fat that were not part of interactions. Animals fed HF diets had reduced
food intake, increased energy intake (Figure 3.9A, B), and increased ABF% (Figure 3.9C). Rats
fed HF diets also had decreased ECW and this significant effect was evident when levels of RS
and WG were collapsed into MF and HF. The significant effect for FAT for increased ECW
with MF diets was presented prior.
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Figure 3.8. Main effect of ABF%, active GLP–1, and inguinal fat. Variables significantly
different between RS and NRS that are present only as main effects. A. active GLP–1, B.
abdominal fat percent (ABF%), and C. inguinal fat. Grouping includes: RS = high resistant
starch, NRS = no resistant starch. Data are shown collapsed to one factor, resistant starch (RS,
Present or Absent), with the other factors whole grain (WG, Present or Absent) and fat (FAT,
High or Moderate) present in both levels of RS. Data are expressed in their original form as
means ± standard error. Different letters above each bar denote significant differences at p<0.05.
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Figure 3.9. Main effect of food intake, energy intake, and abdominal fat percent (ABF%).
Significant difference between MF and HF presented only as main effects. Grouping includes:
MF = moderate fat and HF = high fat. Data are shown collapsed to one factor, fat (FAT, High or
Moderate), with the other factors resistant starch (RS, Present or Absent) and whole grain (WG,
Present or Absent) present in both levels of fat. Data are expressed in their original form as
means ± standard error. Different letters above each bar denote significant differences at p<0.05.
Rats fed HF diets also had decreased ECW and this significant effect was evident when levels of
RS and WG were collapsed into MF and HF. The significant effect for FAT for increased ECW
with MF diets was presented prior.
3.3.2 Real–time quantitative polymerase chain reaction (qPCR)
3.3.2.1 Cecal cells
Amplification and efficiency for RT–qPCR is reported in Table 3.7. All standard curves
for genes expression performed well. The slope and percent efficiency were within acceptable
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ranges, –3.1 to –3.6 and 90 to 110% respectively. Slopes for PPIF and ADM were at the
acceptable range, resulting in 90% percent efficiency. All other slopes were closer to 100%.
Table 3.7. RT–qPCR amplification efficiency in cecal cells.
Standard Curve Equation
(R2)
% Efficiency2
Gene Targets
(y=Ct)1
Adrenomedullin
–3.5914 * (X) + 36.76
0.9932
90
Cyclophilin–F3
–3.5852 * (X) + 26.35
0.9934
90
Galactose–4–epimerase
–3.3575 * (X) + 32.61
0.9916
99
Glucose–6–phosphatase
–3.3385 * (X) + 35.81
0.9848
99
Monocarboxylate transporter member 1
–3.2778 * (X) + 31.94
0.9906
102
Mucin 1
–3.3932 * (X) + 38.92
0.9804
97
Phosphoenolpyruvate carboxykinase 1
–3.2828 * (X) + 28.81
0.9982
102
Pyruvate carboxylase
–3.4675 * (X) + 34.99
0.9778
94
1
Linear equation of standard curve where Ct = (m)*X + b; m = slope, Ct = cycles to threshold on
Y axis, b = y–intercept; solve for copy number (X) which is in terms of arbitrary RNA.
2
The variable % Efficiency is the amplification efficiency. % Efficiency is calculated as
–1

% E = (E–1)*100%, where E = 10 slope .
3
Cyclophilin–F was used as the reference gene (normalizer) for gene expression.
Factorial Interactions
Data were examined and underwent log10 transformation to achieve a normal distribution.
No data points were considered influential or outliers. Dependent variables were ranked by raw
p–values below in Table 3.8 using the B–H FDR test. The most relevant critical value (CV) for
the B–H FDR test was calculated to where p–values were less than the CV.
Table 3.8. Cecal cells gene expression F–test p–values sorted by B–H sorted by B–H FDR1.
RS*WG*FAT
RS*WG
Variables2

p

Variables

Adrenomedullin
Galactose–4–epimerase
Pyruvate carboxylase
Phosphoenolpyruvate carboxykinase 1
Glucose–6–phosphatase
Monocarboxylate transporter member 1
Mucin 1

0.1484
0.1745
0.1772
0.2810
0.2965
0.3631
0.9320

Phosphoenolpyruvate carboxykinase 1
Galactose–4–epimerase
Adrenomedullin
Mucin 1
Pyruvate carboxylase
Monocarboxylate transporter member 1
Glucose–6–phosphatase

Most relevant CV3
(table cont’d.)

0.0071 Most relevant CV3
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p
0.0746
0.3094
0.4985
0.5108
0.6620
0.8180
0.9831
0.0071

RS*FAT
Variables
Pyruvate carboxylase
Phosphoenolpyruvate carboxykinase 1
Adrenomedullin
Mucin 1
Monocarboxylate transporter member 1
Galactose–4–epimerase
Glucose–6–phosphatase

p
0.0117†
0.0369†
0.0839
0.3903
0.6018
0.7354
0.9385

WG*FAT
Variables
Adrenomedullin
Galactose–4–epimerase
Phosphoenolpyruvate carboxykinase 1
Mucin 1
Pyruvate carboxylase
Glucose–6–phosphatase
Monocarboxylate transporter member 1

Most relevant CV3

0.0071 Most relevant CV3
RS

Variables
Adrenomedullin
Phosphoenolpyruvate carboxykinase 1
Monocarboxylate transporter member
1
Mucin 1
Pyruvate carboxylase
Glucose–6–phosphatase
Galactose–4–epimerase
Most relevant CV3
Fat
Variables
Monocarboxylate transporter
member 1
Adrenomedullin
Phosphoenolpyruvate carboxykinase 1
Galactose–4–epimerase
Pyruvate carboxylase
Glucose–6–phosphatase
Mucin 1

p
0.0902
0.1082
0.1215
0.2396
0.3062
0.3255
0.3764
0.0071

WG
p
Variables
p
†
<0.0001 Phosphoenolpyruvate carboxykinase 1 0.0002†
<0.0001† Pyruvate carboxylase
0.0293†
<0.0001† Monocarboxylate transporter member 1 0.1080
<0.0001†
<0.0001†
<0.0001†
0.0006†

Mucin 1
Glucose–6–phosphatase
Adrenomedullin
Galactose–4–epimerase

0.0500 Most relevant CV3

0.1812
0.5199
0.8328
0.9540
0.0071

B–H Critical Values (Q = 0.05)
p

Rank

0.0285† 1
0.0684
0.1631
0.3997
0.4460
0.7999
0.9982

2
3
4
5
6
7

CV
0.0071
0.0143
0.0214
0.0286
0.0357
0.0429
0.0500

Most relevant CV3
0.0071
1
Data are shown based on factors, resistant starch (RS, Present or Absent), whole grains (WG,
Present or Absent) and fat (FAT, High or Moderate).
2
An ANOVA F–test F<0.05 indicates a significant measurement with † superscript denoting
significant difference.
3
Most relevant CV is determined from the greatest significant p–value of dependent variables
(ranked lowest to highest) that is less than the CV at each rank, given I/M*Q. “I” is the rank
number, “M” is the total number of dependent variables (7), and “Q” is the chosen false discovery
rate (0.05).
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Following the PROC MIXED factorial analyses, no RS*WG*FAT, RS*WG, and
WG*FAT interactions were found to be significant. Significant differences for two dependent
variables were observed for the two–way interaction RS*FAT. The results are as follows: PC
(F1,76 = 6.66, p < .0118) and PCK1 (F1,77 = 4.51, p < .0369) (Figures 3.10A, B). The RS*FAT
interactions were further analyzed using a statistical slice on RS and FAT factors (Table 3.9), but
did not pass the B–H FDR test, and are considered falsely detected significant differences.
Table 3.9. Cecal cell gene expression two–way interaction test of effect slices for significant
RT–qPCR variables1,2.
RS * FAT Interaction
RS
FAT
NRS
RS
HF
MF
HF vs. MF HF vs. MF RS vs. NRS RS vs. NRS
Variables
Phosphoenolpyruvate carboxykinase 1
0.5244
0.0389
<0.0001†
<0.0001†
Pyruvate carboxylase
0.1047
0.0517
<0.0001†
<0.0001†
1
Data are shown as collapsed interactions based on significant factors, resistant starch (RS,
Present [RS]; or Absent [NRS]) and fat (FAT, High [HF] or Moderate [MF]).
2
After Bonferroni correction, an adjusted ANOVA F–test p<0.0125 indicates a significant
measurement, denoted with the † symbol.
Factorial Main effects
All genes examined were significant for resistant starch treatment. ADM (F1,45 = 25.82, p <
.0001), G6pc (F1,77 = 105.08, p < .0001), GALE (F1,88 = 12.54, p < .001), MCT1 (F1,88 = 40.79, p
< .0001), MUC1 (F1,67 = 27.56, p < .0001), PC (F1,76 = 78.89, p < .0001), PCK1 (F1,77 = 126.00,
p < .0001). In all measurements, presence of resistant starch resulted in higher gene expression
than without resistant starch. Whole grain presence increased PC (F1,76 = 25.82, p < .05) and
PCK1 (F1,77 = 25.82, p < .0005) gene expression, while MF diets increased MCT1 (F1,45 = 25.82,
p < .05) gene expression (Table 3.10).
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Table 3.10. Descriptive statistics for targeted genes of interest in cecal cells using RT–qPCR1.
Resistant Starch
Pooled
p–value
Variables (arbitrary RNA)
Present
Absent
SEM
(F)2
a
b
Adrenomedullin
6.9626
1.8424
0.5042
<0.0001
Galactose–4–epimerase
3.3166a
1.5489b
0.2574
0.0006
a
b
Glucose–6–phosphatase
7.4548
0.4483
0.5631
<0.0001
Monocarboxylate transporter member 1
2.1805a
0.3784b
0.2234
<0.0001
a
b
Mucin 1
6.7737
2.7526
0.4898
<0.0001
Phosphoenolpyruvate carboxykinase 1
3.8133a
0.5958b
0.2617
<0.0001
Pyruvate carboxylase
13.8082a
1.8125b
1.6224
<0.0001
Whole Grains
Pooled
p–value
Variables (arbitrary RNA)
Present
Absent
SEM
(F)2
Adrenomedullin
4.0224
4.7827
0.5095
0.8328
Galactose–4–epimerase
2.4714
2.3941
0.2565
0.9540
Glucose–6–phosphatase
3.7304
4.1727
0.5241
0.5199
Monocarboxylate transporter member 1
1.6234
0.9355
0.2232
0.1080
Mucin 1
4.6561
4.8702
0.4279
0.1812
a
b
Phosphoenolpyruvate carboxykinase 1
2.4372
1.9719
0.2616
0.0002
Pyruvate carboxylase
9.3947a
7.6068b
0.929
0.0293
Fat
Pooled
p–value
Variables (arbitrary RNA)
Moderate
High
SEM
(F)2
Adrenomedullin
5.4221
3.3829
0.5095
0.0684
Galactose–4–epimerase
2.2203
2.6452
0.2565
0.3997
Glucose–6–phosphatase
3.8528
4.0503
0.5242
0.7999
a
b
Monocarboxylate transporter member 1
1.3206
1.2383
0.2232
0.0285
Mucin 1
4.8065
4.7198
0.4276
0.9982
Phosphoenolpyruvate carboxykinase 1
2.6281
1.781
0.2616
0.1631
Pyruvate carboxylase
9.6111
7.3904
0.929
0.4460
1
Data are shown based on factors, resistant starch (RS, Present or Absent), whole grains (WG,
Present or Absent) and fat (FAT, High or Moderate).
2
An ANOVA F–test p<0.05 indicates a significant measurement. Means with different letters
attached denote significant differences between groups (p<0.05).
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Figure 3.10. Two–way interactions of RS*FAT on pyruvate carboxylase and
phosphoenolpyruvate carboxykinase 1 gene expression. Data are shown collapsed on two
factors in A. PC and B. PCK1 genes expressed. Grouping includes: RS = resistant starch, NRS
= no resistant starch, MF = moderate fat and HF = high fat. Data are expressed as means ±
standard error. Different letters above each bar denote significant differences at p<0.0125. The
line graph figures on the right have the same data and are included for additional visualization.
3.3.2.2 Inguinal Fat
Data could not be appropriately analyzed for inguinal fat gene expression measurements.
Samples either did not amplify sufficiently or standard curves had slopes and R2 measurements
with too poor quality to provide proper normalization and subsequent statistical analyses (Table
3.11). The samples for the 18S rRNA reference gene did amplify well, but the standard curve
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had poor amplification not sufficient enough to provide meaningful normalization. Sufficient
amplification was measured for ANGPTL4 but was unable to be normalized to the reference
gene. Gene targets IL–6, IL–10, LEP, SLC25A25 and TNF–α efficiency was poor due to serial
dilution pipetting error or non–specific product amplification. The gene targets had poor slopes
and were not applicable to further analyzing. Samples adequately amplified for LEP, SLC25A25
and TNF–α. Gene targets IL–6 and IL–10 did not have adequate amplification of standards or
samples, and slope and efficiency measurements were extremely elevated, indicative of non–
specific amplification.
Table 3.11. RT–qPCR amplification efficiency in inguinal fat adipose tissue.
Standard Curve Equation
(R2)
% Efficiency2
Variables
(y=Ct)1
18S rRNA
–2.8559 * (X) + 11.61
0.9985
124
Angiopoietin–like 4
–3.1040 * (X) + 29.22
0.9913
110
Interleukin–6
–1.1871 * (X) + 35.79
0.5221
596
Interleukin–10
–0.7724 * (X) + 36.46
0.4977
1871
Leptin
–2.7310 * (X) + 29.84
0.9849
132
Solute carrier family 25 member 25
–2.9154 * (X) + 33.09
0.9621
120
Tumor necrosis factor–α
–1.7858 * (X) + 34.33
0.8045
236
1
Linear equation of standard curve where Ct = (m)*X + b; m = slope, Ct = cycles to threshold on
Y axis, b = y–intercept; solve for copy number (X) which is in terms of arbitrary RNA.
2
The variable % Efficiency is the amplification efficiency. % Efficiency is calculated as
–1

% E = (E–1)*100%, where E = 10 slope .
3.3.3 Serum
No significant differences for interaction or main effects were observed for serum levels of two
pro–inflammatory markers, CRP and TNF–α, and one anti–inflammatory marker IL–10. All
standards fit the standard curves well and all sample values were within the highest and lowest
standards. Table 3.12 shows the results for these three serum inflammation markers.
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Table 3.12. Serum inflammation markers.
Dietary treatments
RS
RS
NRS
NRS
WG
NWG
WG
NWG
Pooled p–value
MF
MF
MF
MF
SEM
(F)1
Variables
(HF)
(HF)
(HF)
(HF)
C–Reactive protein
282142
304067
296975
315987
12855
> 0.25
(ng/ml)
(256660) (294025) (313542) (233144)
16.6032
19.2855
23.2878
21.6948
Interleukin–10 (pg/ml)
1.6297
> 0.25
(13.9558) (18.6176) (16.6105) (16.4150)
Tumor necrosis factor–α
8.8460
9.9826
7.0597
9.1180
0.3358
> 0.10
(pg/ml)
(8.0018)
(7.2388)
(7.3537)
(8.2119)
1
The ANOVA F–test p–value shown is the lowest p–value between the interactions
(RS*WG*FAT, RS*WG, RS*FAT, WG*FAT) and main effects (RS, WG, FAT).
3.4. Discussion
The study findings support two of the hypotheses, but do not support the third. The
moderate fat diets were better than high fat diets for increasing markers of fermentation with the
high resistant starch diet with no whole grains. High fat diets attenuated this fermentation, and
negatively (increased) energy intake and abdominal body fat, but decreased food intake. The
whole grain resistant starch (flour) prebiotic did not ameliorate the attenuation of fermentation
by high fat diets, and was consistent for both levels of fat. This means that whole grain
combined with resistant starch was effective for maintaining, instead of reducing, fermentation
on moderate and high fat diets, but was not more effective than the isolated resistant starch for
increasing fermentation compared to their respective control group.
Serum markers of inflammation were no different as a response to resistant starch, whole
grain, or dietary fat. The major anti– and pro–inflammatory cytokines, IL–10 and TNF–α
respectively, were similar in concentration, suggesting that gut fermentation of the dietary factors
did not alter systemic levels of cytokines. Similarly, as CRP is elevated as a response to
inflammation, no differences in concentration suggests that whole–body inflammation was not
affected by dietary treatments. Studies with human subjects also exhibit inconsistent changes to
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markers when consuming dietary resistant starch. Johnston et al. (2009) reported no changes in
inflammatory markers in insulin resistant subjects [81], while Gargari et al. (2015) reported
reductions in TNF–α in patients with Type 2 diabetes patients [82]. However in our studies,
Sprague Dawley rats do not have a “disordered state” where resistant starch may be able to
mediate changes in inflammatory status.

Future studies using obese models or transgenic

animals may further elucidate the role of fermentable fiber in altering inflammatory cytokines
and proteins.
Biometric Analyses
Results from the current study demonstrated that the three factors (RS, WG, and FAT)
produced various individual main effects and interactions with each other. Robust effects on
fermentation and phenotype were observed between factors that shape the parameters of
fermentation. There was an observed effect on ECW that approached significance in a three–
way interaction that was primarily driven by the presence or absence of resistant starch. For
many of the dependent variables analyzed, resistant starch, and to a lesser extent fat, appear to be
the primary factors driving observed differences due to large changes in biometric responses
identified in the main effects that were also similar in magnitude in the interactions.
Several of our previous studies demonstrated that consumption of resistant starch was
associated with a reduction in body weight–normalized abdominal body fat.

This was

hypothesized to be the result of increased fermentation because diets with resistant starch and
control diets were isocaloric [3, 4, 9]. Similar observations were noted in this present study
through high resistant starch increasing ECW and active GLP–1, and decreasing ABF% and
EBW. Fermentative ability is observed to be responsive to the interactions of the factors. The
interactions that include resistant starch and whole grains for cecal contents pH, ECW and cecal
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contents acetate, propionate and butyrate illustrate the efficacy of dietary resistant starch for
increasing gut fermentation. These findings suggest that the whole grain control fermented
better than the non–whole grain control because of the presence of a relatively small, but
appreciable amount of RS1. However, the presence of whole grains resulted in greater amounts
of butyrate, but lower amounts of acetate and propionate, suggesting additional utilization of the
whole grain kernel by butyrate producing bacteria.
Within the two–way interactions, there was consistent production of acetate and
propionate with the consumption of whole grains on moderate fat or high fat diets, but reduced
production with the consumption of isolated high resistant starch product under high fat
conditions. This consistent reduction illustrates that fermentation of isolated high resistant starch
was negatively affected by the high fat diet. Increased amounts of butyrate with whole grain
diets may be beneficial as butyrate is a major energy source for the colonocytes [26] and butyrate
is considered beneficial to the health of the gut [83]. Along with lactate produced by the
microbiota, acetate can be utilized by bacteria, in genera such as Clostridium cluster IV and
Clostridium cluster XIV to produce butyrate [31, 32]. Acetate and propionate produced in the
colon can be found in the portal, hepatic and peripheral blood in greater amounts than butyrate
[26]. These SCFAs are utilized by peripheral tissues (muscle, acetate) or by the liver (acetate,
propionate) for metabolism [27–30]. Propionate and butyrate may have a role in modulating
glucose metabolism as propionic acid

and butyric acid act as stimulators of intestinal

gluconeogenesis (IGN) [84]. Butyric acid is a direct stimulator of IGN gene expression and
propionic acid activates a gut–brain neural circuit for IGN gene expression and is a substrate for
IGN. One of the main effects of fermentable fibers is to improve insulin sensitivity by reducing
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hepatic glucose output because of the glucose signaling from IGN. Propionate also influences
regulation of blood pressure through olfactory and G–protein coupled receptors [85].
We hypothesized that a moderate fat diet would result in a similar phenotype (body
weight, ABF%, food and energy intake, etc.) as previously observed with low fat diets, and
possibly lie between low and high fat diets in fermentation parameters (cecal contents pH,
SCFAs, ECW, etc.). Validation of these hypotheses would show that moderate dietary fat
consumption provides greater health benefits than high dietary fat consumption. Our lab group
has shown that moderate fat diets are comparable to low fat diets on ABF% in C57Bl/6J mice
[10] but the ceca and cecal contents were used for microbiota analyses and not analyzed for
routine fermentation dependent variables. In our previous studies, diets low in fat contributed to
a healthier gut (Zhou et al., 2009), while a high fat diet attenuated fermentation and phenotype
effects (Charrier et al., 2013). In the current study, the moderate fat diet was associated with a
lower ABF% and a greater ECW in rats consuming high resistant starch diets compared to those
consuming a high fat diet. However, presence of whole grain with either the presence or absence
of resistant starch showed no differences between high fat and moderate fat consumption. The
latter result indicated our hypothesis that a whole grain resistant starch prebiotic would
ameliorate the negative effects caused by high fat diets was partially validated. However, we
expected that the whole grain resistant starch would ferment better than the isolated resistant
starch with both moderate fat and high fat diets, but it did not.
Whole grains in diets have been shown to have many positive effects on gut and whole
body health [13, 14, 37–43]. However, we observed that whole grains had a complicated role.
For instance, whole grains increased the fermentation variable SCFA butyrate for high fat diets
when compared to diets without whole grains. The disappointing results for whole grains were
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that its presence with resistant starch reduced had fermentation in a moderate fat diet as indicated
by greater cecal contents pH, lower ECW, and SCFA produced except for butyrate compared to
the no whole grain with resistant starch. These results suggest that RS2 is better fermented than
RS1, especially with moderate dietary fat. The isolated resistant starch groups had high–amylose
starch composed of 100% RS2 starch granules. The whole grain resistant starch diet groups had
whole grain flour that was the source of the high–amylose starch, and, therefore, had a
combination of high–amylose starch RS2 granules and RS1 from the whole grain matrix. The
assay for resistant starch does not distinguish between types of resistant starch, only time of
digestion. Thus, our diets were prepared based on total resistant starch. Based on the content of
RS1 in the waxy whole grain flour, that has no high–amylose RS2 starch granules (100%
amylopectin) and only RS1, we estimate that our whole grain resistant starch diets had ~5% RS1
and ~18% RS2 for a total of ~23% resistant starch.
Possible explanations as to why RS2 appears to be more fermentable than RS1 must be
considered. First, the physical arrangement of the starches differs between resistant starch forms.
The high–amylose starch forms granules of RS2 that resist digestion in the small intestine.
Unlike the granules of RS2, the resistant starch in whole grains (RS1) is a component of the food
matrix which acts as a barrier to amylolysis [17]. So we speculate that it is unlikely that RS1
was digested to a greater extent, and it is more likely that bacteria feeding upon these starches
can rapidly ferment the RS2, whereas the whole grain matrix that protects starch as with RS1
requires more time to access and more of it may not be fermented [86]. Secondly, the site of
measurement is important for determining the fermentability of resistant starch. Starch without
the bran (e.g. isolated RS2) is rapidly fermented in the cecum and proximal colon. Govers et al.
(1999) determined that starch with the bran, such as a whole grain starch, is fermented slowly
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and exhibits greater fermentation in the distal colon [86]. The current study measured the effects
of RS2 in the cecum and likely resulted in a substantially greater degree of fermentation using
isolated high–amylose RS2 granules over a combination of RS2 and RS1. This distinction is
useful when examining the differences between resistant starch and whole grain. Regional
differences in fermentation mean differing implications for risk of bowel diseases and SCFA
distribution. Regional fermentation may substantially contribute to the finding that whole grains
can reduce risk of colorectal cancers in the distal colon where most colon cancers occur [39].
This mix of two different types of RS, as well as a variety of fermentable fibers in a varied diet,
has implications for better health of the entire GI tract. In addition, better health of the whole GI
tract would likely lead to a better microbiota, and this in turn would lead to greater physical and
mental health. Improved mental health is now correlated with differences in composition of the
microbiota [87–89].
This RS2 versus RS1 finding is in stark contrast to a previous study conducted by our lab
[90]. In that study, obese Zucker Diabetic Fatty (ZDF) rats fermented the whole grain prebiotic
better with and without resistant starch compared to groups without whole grains in low fat diets.
However, they also fermented the non–whole grain resistant starch well. Although no changes in
body fat were observed, ZDF rats demonstrated substantial increases in fermentation and
alterations to the microbiota. Prior to conducting the study, ZDF rats were thought to be
dysbiotic and poor fermenters of resistant starch, whereas Sprague Dawley (SD) rats had
previously been shown to ferment resistant starch robustly and have reduced ABF% [89, 91, 92].
The study with obese ZDF rats was our first study using the whole grain high resistant starch
product and we switched to Sprague Dawley rats anticipating a similar response to whole grain

52

high resistant starch, but to also observe the reduced ABF%. Thus, our results with the whole
grain resistant starch were unexpected.
Charles River company had developed separate Sprague Dawley colonies by phenotype
with obese–prone (OP) and obese–resistant (OR) based on consumption of high fat diets but both
had more body fat than typical Sprague Dawley colonies [93].

The genotype behind this

phenotypic difference has not been delineated (personal communication with the local
representative of Charles River animal supplier company) and is likely multigenic and more
complex than many other rodent obesity models like the obese ZDF rat. Obesity in ZDF rats is a
monogenic trait, where the leptin receptor is defective. In the current study, used Sprague
Dawley rats from our usual supplier of these rats (Envigo, Somerset, NJ) as in our previous
studies that are we did not separate by phenotype. Our previous studies with Sprague Dawley
rats appeared not to be affected by possible different phenotypes as all except one used low fat
diets.

In the one study in which we did compare low fat and high fat diets fed to Sprague

Dawley rats [9], we only used diets with isolated high–amylose RS2 starch granules and were
not aware of an effect of the different phenotypes. Our current results with Sprague Dawley rats
demonstrate that the rats with an unknown mix of phenotypes we received for the study appear
not to ferment RS1 in a whole grain product as well as the obese ZDF rats [90], especially as part
of a moderate fat diet.
The results from the current study support our previous studies and continue to
demonstrate the benefits of consuming resistant starch. In addition, the benefits of moderate fat
diets and whole grain products were also demonstrated. Moderate fat diets appear to be as
effective as low fat diets in promoting fermentation of resistant starch and other effects including
reduction of abdominal body fat normalized to body weight. Whole grain products demonstrated
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consistent fermentation in both high and moderate fat diets and appear to promote nourishing the
gut by increasing butyrate production. However, the phenotype mix of Sprague Dawley rats
(OP, OR) may affect the response to resistant starch and whole grain products. This suggests
that the Sprague Dawley rat is likely a good model for investigating prebiotic substances, but the
two phenotypes possibly should be separated for more consistent results. . Additionally, our
results indicate that different rat types appear to have different microbiota that affects their
responses to the whole grain high resistant starch product
Gene Expression
The role of the gut as a gluconeogenic organ has been not been resolved. Currently, as
evidence accumulates, the consensus is moving towards supporting the hypothesis. Here we
provide additional evidence that several genes, likely through microbial fermentation, are
upregulated in the gluconeogenesis pathway in the cecum. Pyruvate Carboxylase (PC, pyruvate
to

oxaloacetate),

phosphoenolpyruvatecarboxykinase

1

(PCK1,

oxaloacetate

to

phosphoenolpyruvate) and further along the pathway glucose–6 phosphatase (G6pc, glucose–6–
phosphate to glucose) genes demonstrate increased gene expression when rats were fed resistant
starch, and to lesser extent, whole grain diets. Although we did not measure insulin sensitivity in
the current study, the increased gene expression of cecal gluconeogenic enzymes suggests an
enhancement of insulin sensitivity through improved glucose homeostasis.

Though

gluconeogenesis genes are known to be expressed in the small intestine [94], we report
upregulation of IGN gene expression at the site of fermentation likely through utilization of and
RS2 as a fermentable substrate in the cecum.
Increased gene expression does not always mean increased translation to the protein and
increased amounts of the protein. Therefore, we measured the major regulatory protein in the
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gluconeogenesis pathway in the rat, PCK1 (cytoplasmic). It was observed that resistant starch,
especially in whole grain diets, had increased amounts of the protein, which further indicated
increased IGN in the cecum. This is somewhat surprising because we believe that the RS1 was
fermented to a lesser extent in the cecum and would be fermented in the distal colon.
Increased oxidative stress is reported to contribute to insulin resistance [95, 96].
Adrenomedullin (ADM) suppresses reactive oxygen species which inflame adipose tissue due to
overutilization of mitochondrial oxidative phosphorylation in adipose tissue [97, 98].

We

observed a four–fold increase in ADM gene expression when rats were fed resistant starch.
Though we did not measure insulin sensitivity, our observation indicates the potential for
improved insulin sensitivity. An additional role of ADM as a potent vasodilator and a stimulator
of angiogenesis imply a reduction to hypoxic injury and increased blood flow to the gut with
increased fermentation and healthy growth of the cecum. The possibility of increased blood
flow, reduced oxidative stress and increased gluconeogenic capacity, as a result of microbial
fermentation of resistant starch, illustrates possible improved gut health and the potential to lead
to improvements in physical and mental health.
Microbial fermentation also improves the colonic barrier and improves goblet cell
function. The intestinal epithelium is important for innate host defense, primarily for its barrier
between the host and microbial communities, pathogenic or not. Akkermansia muciniphilia, a
mucin degrading bacterium, is considered beneficial for gut health, however in sufficiently large
quantities, colonization of A. muciniphilia is detrimental to gut health with patients afflicted with
IBD [99]. Aiding this barrier is the colonic mucus layer formed from goblet cells secretions.
Galactose–4–epimerase (GALE) catalyzes the first step in the mucin biosynthesis pathway, while
membrane–bound mucin 1 (MUC1) expression is partly responsible (with other mucins) for the
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O–glycosylated proteins that form the protective mucus barrier lining the epithelial surface.
Dietary resistant starch upregulated gene expression of GALE and MUC1, demonstrating a
twofold increase over the non–resistant starch condition.

Resistant starch induced mucin

biosynthesis provides a better barrier for the intestinal epithelium, and may improve heath for
patients afflicted with IBD. A relatively recent report [100] demonstrated that fermentable fiber
is needed in the diet to support the maintenance of bacteria that limit by competition, the mucin–
degrading bacteria to maintain a healthy mucus barrier to prevent bacterial access to the
epithelial cells of the GI tract.
Coinciding with increased gut fermentation is the production of SCFAs. Uptake of
produced SCFAs is partly facilitated by monocarboxylate transporters located on the epithelial
plasma membrane. As butyrate is the main energy source for the colonocytes, increased gut
fermentation provides an abundance of energy for the microbial community and one of its
products provides energy for these cells. Increased expression of monocarboxylate transporter 1
(MCT1) illustrates increased capacity for uptake of SCFAs, and should improve gut health. We
observed increased expression of the transporters when rats were fed high resistant starch, but
lower amounts with the high fat diet that attenuates fermentation parameters with the high–
amylose RS2. Fermentation of dietary resistant starch provided a fivefold increase in gene
expression, suggesting that availability of energy is monitored by the colonocytes and uptake
capacity is equivalent with microbial SCFA production. However, this also suggests that diets
higher in fat produce less gut fermentation overall, with decreased production of SCFAs leading
to decreased capacity for uptake being more energetically favorable for the cells.
Ravussin et al. (2012) demonstrated correlations between inguinal adipose adipokines
(ANGPTL4, IL–10, TNF–α, and SLC25A25) that were negatively related to increases in
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bacterial genus Allobaculum [8]. In this study, we were unable to replicate these findings. Our
RT–qPCR experiments did not produce acceptable amplification for individual samples, even for
ANGPTL4 which had a good standard curve. Unlike the measurements in cecal cells, RNA
extracted from inguinal adipose required additional cleanup and concentration steps to obtain
appropriate quality. It is not understood why Ravussin et al. had successful results with inguinal
fat and our lab could not replicate their results despite what appeared to be clean and
concentrated RNA.
Although isolated high–amylose RS2 granules in the diet had its greatest effect with a
moderate fat diet and exhibited greater fermentation than whole grain high resistant starch, we
observed a substantial benefit to gut health through feeding diets that included fermentable
fibers. Dietary resistant starch, whole grains, and both moderate and high dietary fat improved
gut health through microbial induced fermentation. Subsequently, improved gut health resulting
from the enhanced ability to nourish and protect itself furthers the co–expression of genes that
benefit from the availability of fermentable fiber. Potentially increased blood flow, reduced
oxidative stress and gluconeogenic capacity, as a result of microbial fermentation of resistant
starch, illustrated improved gut health that can indirectly lead to the improvement of whole body
health.
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CHAPTER 4. A DOSE RESPONSE ANALYSIS OF FERMENTATION IN
LEAN ZUCKER DIABETIC FATTY RATS FED WHOLE GRAIN
RESISTANT STARCH
4.1. Introduction
Epidemiological studies continue to demonstrate an association between decreased risk
for obesity and chronic disease and increased consumption of fiber and whole grains [71].
However, current policies for fiber intake recommend twice the fiber amount that the average
U.S. adult consumes [1, 12]. This issue is further exacerbated, because fiber intake is directly
mediated by food intake.

The prevalence of sugar– and fat–rich products available

commercially, combined with diets that recommend low carbohydrate intake, produce an
environment where dietary fiber intake has been an afterthought in consumer’s purchasing and
consumption habits. Regrettably, to abstain from dietary fiber is also to diminish the potential
benefits induced from the availability of fermentable fibers.
Consumption of fermentable fiber stimulates the growth and maintenance of the gut
microflora [22]. The microbial community, in turn, stimulates or produces many end products,
including metabolically useful gut hormones and short chain fatty acids (SCFAs). Resistant
starch (RS), a fermentable fiber, resists enzymatic digestion in the small intestine and is capable
of fermentation in the lower gut, the colon [19]. Diets including RS have been shown to induce a
suite of metabolically favorable outcomes, including improved plasma glucose and insulin
responses [57, 58], mineral absorption [56], and reduced risks of cardiovascular disease and
cancers [39–41].
Similarly, whole grain (WG) consumption has been associated with reduced risk for
cardiovascular disease, type 2 diabetes [37, 38], cancers [39–41], and all–cause mortality [42,
43]. Like dietary fiber, whole grain intake has remained less than the recommended amounts
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despite the benefits derived from consumption and fermentation [47]. At the time of our studies,
a whole grain flour product from a natural corn variety with lower amylopectin than typical corn
was available for comparison with the isolated starch from this same corn product.

This

comparison was addressed in chapter 3. In the current study, this whole–grain resistant starch
(WGRS) product was more thoroughly studied in a dietary dose response design using lean
Zucker Diabetic Fatty (ZDF) rats. The change from Sprague Dawley rats to lean ZDF rats was
because Sprague Dawley rats fermented the isolated RS product better than the WGRS. In our
previous study, obese ZDF rats fermented the WGRS better than the isolated RS product [90].
However, the obese ZDF rats had no reduction in ABF% likely due to their defective leptin
receptor. We hypothesized that the lean ZDF rats would also ferment the whole grain product to
a greater extent than the isolated RS product.
The WGRS has both RS1 and RS2. The RS1 exists because the matrix of the whole
grain kernel in the flour prevents access of the amylase enzymes to the starch; and the RS2 exists
because of the granular structure of the high–amylose starch granules [77]. Thus, WGRS has a
combination of RS1 and RS2. The whole grain control group was fed a diet that included a
waxy whole grain flour product. This product also comes from a natural corn variety, but this
product has 100% amylopectin for its starch component. Therefore, the waxy whole grain
product has RS1, but no RS2. The amount of the waxy whole grain product used in the study
resulted in ~2% of the diet as RS1.
Identifying a minimal level of fiber intake to improve gut health remains imperative. It is
estimated that ~10% of the weight of the diet in rats is equivalent to the recommendation for
fiber consumption for humans [101]. Mechanistic, proof–of–concept doses of fiber designed to
elicit strong responses to gut fermentation in rats have already shown favorable results [9, 23,
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93]. In the current study, the aim was to determine if an effective lower dose was beneficial for
gut health. The objectives were to (1) determine if whole grain alone (RS1 without RS2) was
effective as a fermentable fiber compared to non–whole grain or RS fiber, and (2) determine
which dose of WGRS was different from the waxy whole grain product without RS2. The
hypothesis was that WGRS would be effective in providing health benefits at all doses included
in the study that included 5, 10, 15, and 20% compared to the waxy whole grain control.
4.2. Methods
Diets
Diet treatments were adapted from AIN–93M purified diets for rodents (Table 4.1) [76]. Diets
contained one major starch source as either an isolated starch product or as whole grain flour.
Starches and whole grain flours were analyzed by proximate analysis (Medallion Labs for
Ingredion Incorporated). Starches included: (1) AMIOCA® waxy corn starch, (2) Waxy whole
grain corn flour, or (3) HI–MAIZE whole grain resistant corn flour. Diets with RS were
calculated to contain increasing delineations by weight. The waxy whole grain starch was
calculated to have 2.0% RS, due to the whole grain kernel containing a resistant starch
component in the bran when not overly processed. RS content was determined by Ingredion
Incorporated using the modified Englyst Assay [78].

Isocaloric diets were formulated to

provide 3.70±0.001 kcal/g energy.
Table 4.1. Diet composition.
1

Ingredients
Waxy corn starch2
Waxy whole
grain flour3
(table cont’d.)

CON
Grams
454.80
0.00

5%
10%
15%
20%
WG
HMWG HMWG HMWG HMWG
Grams
Grams
Grams
Grams
Grams
166.20 396.10 337.20 278.50 219.60
350.9
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0.00

0.00

0.00

0.00

1

CON
Grams

WG
Grams

5%
10%
15%
20%
HMWG HMWG HMWG HMWG
Grams
Grams
Grams
Grams

Ingredients
High–amylose
0.00
93.10 186.20 279.30 372.40
0.00
whole grain starch
100.00 100.00 100.00 100.00 100.00 100.00
Sucrose
4
140.00 112.63 131.71 123.43 115.15 106.90
Casein
88.72
68.32
47.89
129.50 109.17 109.11
Cellulose
5
70.40
79.40
73.80
68.10
62.50
85.00
Corn oil
5
42.50
42.50
42.50
42.50
42.50
42.50
Lard
35.00
35.00
35.00
35.00
35.00
35.00
Mineral mix
10.00
10.00
10.00
10.00
10.00
10.00
Vitamin mix
1.40
1.40
1.40
1.40
1.40
1.40
Choline chloride
1.80
1.80
1.80
1.80
1.80
1.80
L–Cystine
1000.00 1000.00 1000.00 1000.00 1000.00 1000.00
Total
6
2.00
5.00
10.00
15.00
20.00
0
Resistant Starch, %
3700.10 3700.00 3700.20 3700.00 3700.10 3700.20
Total Energy, kcal
1
Diets include: CON = Amylopectin control corn starch containing no resistant starch diet;
WG = waxy whole grain amylopectin control corn flour containing low resistant starch diet;
X% HMWG = whole grain high–amylose maize resistant corn starch diet.
2,3
Waxy & high–amylose corn starches and whole grain flours were gifts from Ingredion
Incorporated (Bridgewater, NJ).
4
Casein was reduced in each diet based on the protein constituent in AMICOA® and HI–
MAIZE® corn starches and whole grain flours analyzed by proximate analysis performed by
Medallion Labs for Ingredion Incorporated, and differs from the AIN–93M standard 140 g/kg.
5
Corn oil was modified in each diet based on the fat content in AMICOA® and HI–MAIZE®
corn starches and whole grain flours analyzed by proximate analysis performed by Medallion
Labs (Minneapolis, MN) for Ingredion Incorporated (Bridgewater, NJ), and differ from the
AIN–93M standard 40 g/kg. Corn oil and lard were calculated to adjust fat present in all diets to
~ 18% of energy.
6
Diets with high amylose starch contain resistant starch type 2, but the whole grain flour with
high amylose has both resistant starches 1 and 2. Diets with waxy whole grain flour contain
only resistant starch type 1. Resistant starch content of experimental starches was determined
by Ingredion Incorporated using modified Englyst assay [78].
Animals & Euthanasia
Sixty–eight male Lean Zucker rats (Fa +/?) were purchased from Envigo (Somerset, NJ) at six
weeks of age, and maintained on a chow diet during a one week quarantine. Rats were then
stratified randomly by body weight into six groups (n=11; n=12 5%, 10% HMWG; average
159.4±12.6 grams). Treatment groups consisted (1) control starch with no WG or RS [CON], (2)
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whole grain waxy corn flour with low RS [WG], (3–6) WG high–amylose maize flour rich in
resistant starch (WGRS) [x% HMWG] (Figure 4.1). All animals were housed in a locked facility
in individual stainless steel hanging cages with wire mesh bottoms to measure food spilled and
prevent coprophagy. Housing environmental conditions included a 12:12h light–dark cycle, 21–
22°C ambient temperature with a 55% relative humidity. Animals were allowed ad libitum
access to food and water, and for six weeks. Food intake, food spilled, and body weight were
measured twice per week. Rats were then euthanized and exsanguinated by cardiac puncture
after inhalation of isoflurane anesthesia delivered by soaked cotton balls. For each rat, blood
samples were collected with dipeptidyl peptidase IV inhibitor for additional analyses. The
gastrointestinal (GI) tract was removed from the base of the esophagus to the anus, separated into
individual parts (stomach, small intestine, cecum, and large intestine) and weighed full and
empty. Subcutaneous inguinal adipose and abdominal fat pads (epididymal, perirenal, and
retroperitoneal) were collected and weighed to determine percentage of abdominal fat (ABF%).
Abdominal fat percent was calculated as the abdominal fat pads divided by the body weight of
the rat with the GI tract contents weight removed (ABF =

Abdominal Fat Pads
* 100).
Body weight – Full GI + Empty GI

Cecal contents were collected and divided into 0.5 g aliquots, and frozen in liquid N2 for
measurement of pH and short–chain fatty acids (SCFAs). Cells lining the ceca, inguinal and
epididymal fat pads were flash frozen in liquid N2 and stored at –80°C until later analysis. The
protocol for this study was approved by the Louisiana State University Institutional Animal Care
and Use Committee, protocol 13–088.
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Figure 4.1. Experimental design. Study was designed as a dose–response to increasing
percentage of whole grain resistant starch. Each whole grain resistant starch group (n=12; n=11
for 10% and 15% RS) contains an increased level of fermentable fiber. AMIOCA® and Whole
grain controls (n=12) contain digestible fiber.
Blood measurements
Serum active glucagon–like peptide 1 (GLP–1, ALPCO, NH), and C–reactive protein (CRP),
tumor necrosis factor alpha (TNF–α), and interleukin–10 (IL–10, ThermoFisher, Waltham, MA)
levels were measured with enzyme–linked immunosorbent assay (ELISA) kits.
Cecal contents pH and short–chain fatty acids analysis
Cecal contents were thawed and 0.5 g of sample was homogenized with 5 ml of distilled
water for pH measurements. Wet and dry weights were measured for each sample. Each sample
was then acidified with 1 ml 25% (wt/wt) solution metaphosphoric acid containing a 2 g/L 2–
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ethyl–butyric acid internal standard. Solids were separated by centrifugation at 8,000 X g for 10
minutes and filtered through a Millipore filter (MILX HA 33 mm, 0.45 μm MCE STRL; Fisher
SLHA 033SS). The filtered supernatant was transferred to a gas chromatograph (GC)
autosampler vial.

SCFAs were analyzed by gas–liquid chromatography for quantitative

determination. Detailed methods for quantification of SCFAs via GC have been described in
previous publications from our lab [9].
Quantitative real–time PCR (qPCR)
RNA was extracted from cecal cells and inguinal adipose using the RNeasy Mini Kit and
RNeasy Lipid Tissue Mini Kit respectively (Qiagen, Valencia, CA). Samples with a poor
260/230 absorption spectra ratio (lower than 1.8) were purified using GeneJet RNA Cleanup and
Concentration Micro Kits (ThermoFisher Scientific, Waltham, MA). TaqMan® Gene Expression
Assays (ThermoFisher, Waltham, MA) were used to measure intestinal gluconeogenesis (IGN)
(glucose–6–phosphatase
carboxykinase 1 (PCK1)),

(G6pc),

pyruvate

carboxylase

(PC),

phosphoenolpyruvate

colonic barrier and goblet cell function (UDP–galactose–4–

epimerase (GALE), monocarboxylate transporter member 1 (MCT1), mucin 1 (MUC1)), and
response to oxidative stress (dual specificity protein phosphatase 1 (DUSP1)) in cecal cells.
TaqMan® Gene Expression Assays (ThermoFisher, Waltham, MA) were used to measure pro–
inflammatory status (IL–6, TNF–α), anti–inflammatory status (IL–10), and bacterial
manipulation (angiopoietin–like 4 (ANGPTL4), leptin (LEP), solute carrier family 25 member 25
(SLC25A25)) in inguinal adipose tissue. Cecal cell and inguinal adipose gene expression were
normalized using Cyclophilin–F (PPIF) and 18S rRNA, respectively.
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DNA extraction and Next Generation DNA Sequencing and Bioinformatics
DNA was extracted by Louisiana State University Health Sciences Center. Purified
DNA was sequenced using a MiSeq instrument after massive parallel PCR amplification was
used to incorporate primers with barcodes to identify individual samples. Relative abundance of
bacteria was determined using Quantitative Insights Into Microbial Ecology (QIIME) 1.9 and
DaDa2 package pipeline assembly to assign operational taxonomic units (OTU) for use in
determination of alpha– and beta–diversity.
Statistical Analysis
Statistical analysis was performed using Statistical Analysis Software SAS® version 9.4
(SAS Institute Inc., Cary, NC, USA). A one–way ANOVA with a priori contrasts comparing
each treatment to WG was performed using the MIXED procedure. The model used the dietary
treatment as a fixed effect, and did not use random effects. Denominator degrees of freedom for
fixed effects used the Kenward–Roger approximation. Benjamini–Hochberg false discovery rate
(B–H FDR) was then used to screen dependent variable F–test p–values [80]. The B–H FDR
procedure consists of ranking (indexing) the raw p–values from lowest to highest and then
comparing each to the critical value (CV), which is determined by the formula “I/M*Q”. “I” is
the rank number, “M” is the total number of dependent variables, and “Q” is the chosen false
discovery rate. The largest p–value less than the CV and all smaller p–values pass the FDR test.
A Q = 0.05 was chosen as the false discovery rate.
If a dependent variable passed the FDR test, the F–statistic and subsequent p–value were
considered valid. Homogeneity of variance and influence diagnostics were tested within the
MIXED procedure, while tests for normality were conducted using the UNIVARIATE
procedure. A null model likelihood ratio test (χ2) was performed determine if variance was
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homogeneous or heterogeneous.

If variance was homogeneous, then normality testing of

residual values used pooled group residuals. Heterogeneous variance proceeded with variance
calculated for each group. Influential outliers, tested using studentized residuals and leverage,
were removed only if their presence prevented normal distribution for statistical analysis.
Influences on parameter estimates were examined using Cook’s D.

Data from dependent

variables that violated the normality assumption were transformed to log10. Following log10
transformation, normality and homogeneity of variance testing were reapplied. Data violating
the normality assumption after transformation was considered not normally distributed and
reverted to raw data. The following variables were transformed due to non–normal distribution
(p<0.05 for Shapiro–Wilk test): SCFAs acetate, propionate, and butyrate in ceca. Transformed
dependent variables were back–transformed by taking the antilog. An F–statistic of F<0.05 was
considered statistically significant for fixed effects and results are expressed as means ± pooled
SE.
4.3. Results
A dose response relationship in observed when feeding whole grains and whole grain resistant
starch. All doses related to fermentation parameters (SCFA, cecal contents pH, empty cecum
weight) were effective, even if nominally, when RS was present. Whole grain alone is beneficial
for increased production of short–chain fatty acids. Rats fed high RS (HMWG) had no soft or
loose stools during the study. This was the same as our previous study with obese ZDF rats [90].
4.3.1. Biometric Analysis
Data were examined and influential outliers removed. Two data points were removed for
ECW (AC 0.6515, 20% RS: 1.0228). One AC treatment rat was missing measurements for
SCFA and pH measurements and was not included in the analysis. The F–test p–values were
subjected to the B–H FDR procedure (Table 4.2). Seven of the eleven dependent variables
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appeared to not be false discoveries. For these variables, we proceeded to perform multiple
comparisons using a priori contrasts.
Empty Cecum weight and cecal contents pH
Planned contrasts of each of five groups compared to the waxy whole grain control
revealed an increase in fermentation beginning at the 5% dietary RS level as indicated by a
decrease in cecal contents pH (Figure 4.2A), but an increase in ECW was only evident at 10%
and above (Figure 4.2B). At the 10% RS level and beyond, ECW increased linearly. No
statistical differences were noted between the waxy whole grain control, the non–whole grain
control, and 5% RS treatment.
Table 4.2. Biometric analysis ANOVA F–test p–value sorted by B–H FDR procedure.
B–H Critical Values (Q = 0.05)
Variables
p1
Rank
CV
†
Acetate (µmol)
<0.0001
1
0.0045
Propionate (µmol)
<0.0001†
2
0.0091
†
Butyrate (µmol)
<0.0001
3
0.0136
Emboweled body weight (g)
<0.0001†
4
0.0182
†
Empty Cecum Wt. (g)
0.0010
5
0.0227
6
0.0273
Cecal contents pH
0.0010†
2
Abdominal body fat %
0.3383
7
0.0318
Inguinal fat (g)
0.5225
8
0.0364
Active GLP–1 (pM)
0.8476
9
0.0409
3
Food Intake (g)
0.9382
10
0.0455
Energy intake (kcal)
0.9382
11
0.0500
Most relevant CV4
0.0273
1
An ANOVA F–test p<0.05 indicates a significant measurement with † superscript denoting
significant differences among the six groups.
Abdominal Fat Pads
2
ABF%: Body weight – Full GI + Empty GI * 100
3

Food intake over the whole study of 6 weeks.
Most relevant CV is determined from the greatest significant p–value of dependent variables
(ranked lowest to highest) that is less than the CV at each rank, given I/M*Q. “I” is the rank
number, “M” is the total number of dependent variables (11), and “Q” is the chosen false
discovery rate (0.05).
4
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Figure 4.2. Response to increasing dosage of RS on weight of empty cecum and cecal contents
pH. Grouping includes: AC = non–whole grain, non–RS control, WG = waxy whole grain, [5,
10, 15, 20%] RS = whole grain resistant starch. Significant differences as compared to WG are
denoted with an asterisk. Data are expressed in their original form as means ± standard error.
Short chain fatty acids acetate, propionate, and butyrate
Planned contrasts of each of five groups compared to the waxy whole grain control demonstrated
an increased production of acetate at the whole grain level vs. the non–whole grain control and
increased sequentially as dosage increased (Figure 4.3A). Contrasts for propionate production
continued the trend, although 5% RS was visually higher than 10% RS (Figure 4.3B).
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Figure 4.3. Response to increasing dosage of RS on short chain fatty acid production. Grouping
includes: AC = non–whole grain, non–RS control, WG = waxy whole grain, [5, 10, 15, 20%] RS =
whole grain resistant starch. Significant differences as compared to WG are denoted with an
asterisk. Data are expressed in their original form as antilog means ± standard error.
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Butyrate production saw no statistical differences at the 5% RS levels, but was increased
similarly for the 15% and 20% RS levels (Figure 4.3C) as visually determined as these two
groups were not statistically compared. However, the waxy whole grain control had greater
amounts of butyrate than the non–whole grain control.
Emboweled Body weight
Planned contrasts of each of five groups compared to the waxy whole grain control showed a
non–linear reduction in EBW starting as low as 5% RS (Figure 4.4). There was no difference, or
even a whole grain effect, to reduce EBW when there was no presence of the high amylose,
whole grain flour.
350
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Figure 4.4. Response to increasing dosage of RS on emboweled body weight. Grouping includes:
AC = non–whole grain, non–RS control, WG = waxy whole grain, [5, 10, 15, 20%] RS = whole
grain resistant starch. Significant differences as compared to WG are denoted with an asterisk.
Data are expressed in their original form as means ± standard error.
Food Intake, Energy Intake, Abdominal body fat percentage and inguinal adipose
Planned contrasts of each of five groups compared to the waxy whole grain control showed no
differences in food intake and energy intake (Table 4.3). Additionally, the percentage of
abdominal fat and inguinal adipose were not different from the WG control.
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Table 4.3. Intake parameters and body fat descriptive statistics.
Pooled
Variables
WG
AC
5%
10%
15%
20%
SEM
Food Intake (g)1
789.35 798.02 803.58 805.66 796.06 810.96 120.63
Energy Intake (kcal)
2920.60 2952.66 2973.23 2980.95 2945.41 3000.57 446.31
Abdominal body fat %2 4.86
4.22
4.57
4.64
4.31
4.26
1.86
Inguinal fat (g)
8.00
6.60
7.49
7.40
6.76
6.87
1.77
1
Food intake over the whole study of 6 weeks.
Abdominal Fat Pads
2
ABF%: Body weight – Full GI + Empty GI * 100

p–value
(F)
0.9382
0.9382
0.3380
0.5225

4.3.2. Real–time quantitative polymerase chain reaction
4.3.2.1. Cecal cells
Amplification and efficiency for RT–qPCR is reported in Table 4.4. All standard curves
for genes expression performed well. Slope and percent efficiency were within acceptable
ranges, –3.1 to –3.6 and 90 to 110% respectively. The slope for PC was slightly above the
acceptable range, resulting in percent efficiency slight below 90%.
Table 4.4. RT–qPCR amplification efficiency in cecal cells.
Standard Curve Equation
(R2)
% Efficiency2
Variables
(y=Ct)1
Cyclophilin–F3
–3.4334 * (X) + 24.67
0.9897
96
Dual specificity protein phosphatase 1
–3.4630 * (X) + 34.76
0.9916
94
Galactose–4–epimerase
–3.5507 * (X) + 34.76
0.9986
91
Glucose–6–phosphatase
–3.3160 * (X) + 40.02
0.9836
100
Monocarboxylate transporter member 1
–3.3000 * (X) + 35.02
0.9987
101
Mucin 1
–3.1736 * (X) + 41.70
0.9153
107
Phosphoenolpyruvate carboxykinase 1
–3.1692 * (X) + 32.63
0.9983
107
Pyruvate carboxylase
–3.6042 * (X) + 34.06
0.999
89
1
Linear equation of standard curve where Ct = (m)*X + b; m = slope, Ct = cycles to threshold on
Y axis, b = y–intercept; solve for copy number (X) which is in terms of arbitrary RNA.
2
The variable % Efficiency is the amplification efficiency. % Efficiency is calculated as
–1

% E = (E–1)*100%, where E = 10 slope .
3
Cyclophilin–F was used as the reference gene (normalizer) for gene expression.
Data were examined and underwent log10 transformation. Under transformation, data
were normally distributed. No influential measures were present for PC (F1,30 = 1.41, p > 0.250)
and MCT1 (F1,30 = 2.60, p < 0.0500). Influential data were removed from DUSP1 (F1,9 = 1.75, p
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> 0.200) and GALE (F1,9 = 1.20, p > 0.300), but results were not significant. Two influential
measurements were removed from PCK1 (F1,28 = 4.28, p < 0.0100). Samples, unknowns, did not
sufficiently amplify for statistical analysis of G6pc and MUC1 genes. Five dependent variables
were ranked by p–values below in Table 4.5 using the B–H FDR procedure.
Table 4.5. Cecal cell gene expression ANOVA F–test p–value sorted by B–H FDR.
B–H Critical Values (Q = 0.05)
Variables
p1
Rank
CV
†
0.0100
Phosphoenolpyruvate carboxykinase 1 0.0051 1
Monocarboxylate transporter member 1 0.0455† 2
0.0200
Pyruvate carboxylase
0.1824 3
0.0300
Dual specificity protein phosphatase 1
0.2171 4
0.0400
Galactose–4–epimerase
0.4056 5
0.0500
Glucose–6–phosphatase2
N/A
Mucin 12
N/A
Most relevant CV3
0.0100
1
An ANOVA F–test p<0.05 indicates a significant measurement with † superscript denoting
significant differences among the six groups.
2
Target gene in samples did not amplify sufficiently enough for meaningful statistical analysis.
3
Most relevant CV is determined from the greatest significant p–value of dependent variables
(ranked lowest to highest) that is less than the CV at each rank, given I/M*Q. “I” is the rank
number, “M” is the total number of dependent variables (5), and “Q” is the chosen false discovery
rate (0.05).
The PCK1 gene was upregulated only under 10% RS treatment.

The MCT1 gene was

upregulated in the AC, 5% RS, and 20% RS treatments. Although the MCT1 gene was
significant, it did not pass the B–H FDR procedure and was considered a falsely detected
significant difference. Untransformed data are shown below in Table 4.6.
Table 4.6. Cecal cell gene expression descriptive statistics reported as arbitrary RNA1.
Pooled
Variables
WG
AC
5%
10%
15%
20%
SEM
Dual specificity protein
1.2145 1.9411 0.501 0.8337 0.7578 1.0913 0.4985
phosphatase 1
Galactose–4–epimerase 0.2873 0.2716 1.592 0.3944 0.3566 0.4151 0.1372
Glucose–6–phosphatase
–
–
–
–
–
–
–
Monocarboxylate
0.1212 1.6279† 1.0664† 0.2385 0.5926 0.9836† 0.2003
transporter member 1
Mucin 1
–
–
–
–
–
–
–
(table cont’d.)
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p–value
(F)2
0.2171
0.4056
–
0.0455†
–

Pooled p–value
Variables
WG
AC
5%
10%
15%
20%
SEM
(F)2
Phosphoenolpyruvate
0.2462 0.0937 0.1196 0.6686† 0.3242 0.4206 0.0632 0.0051†
carboxykinase 1
Pyruvate carboxylase
0.6365 0.175 0.2424 0.7567 0.6037 0.7751 0.1199 0.1824
1
Data presented untransformed. Statistical significance was determined using log10 transformation.
2
An ANOVA F–test p<0.05 indicates a significant measurement with † superscript denoting
significant differences when compared individually to WG.
4.3.2.2. Inguinal fat
Data could not be completely analyzed for inguinal adipose gene expression
measurements. Samples either did not amplify sufficiently or standard curves had slopes and R 2
measurements of too poor of quality to provide proper normalization and subsequent statistical
analyses (Table 4.7). Standard curves for the 18S rRNA reference gene, ANGPTL4, LEP, and
SLC25A25 had good amplification, but samples have not been analyzed to determine gene
expression due to new normalization techniques being employed. ANGPTL4 efficiency was
outside of acceptable error with a value of 113% either due to serial dilution pipetting error or
non–specific product amplification. The TNF–α gene target had a very poor slope and was not
applicable for further analyzing. Gene targets IL–6 and IL–10 did not see amplification of
standards or samples, and slope and efficiency measurements could not be calculated.
Table 4.7. RT–qPCR amplification efficiency in inguinal adipose tissue.
Standard Curve Equation
(R2)
% Efficiency2
Variables
(y=Ct)1
18S rRNA
–3.2680 * (X) + 11.70
0.9925
102
Angiopoietin–like 4
–3.0543 * (X) + 32.23
0.9973
113
Interleukin–6
–
–
–
Interleukin–10
–
–
–
Leptin
–3.6008 * (X) + 30.32
0.9866
90
Solute carrier family 25 member 25
–3.1969 * (X) + 31.41
0.9621
105
Tumor necrosis factor–α
–8.7944 * (X) + 38.11
0.5877
30
1
Linear equation of standard curve where Ct = (m)*X + b; m = slope, Ct = cycles to threshold on
Y axis, b = y–intercept; solve for copy number (X) which is in terms of arbitrary RNA.
2
The variable % Efficiency is the amplification efficiency. % Efficiency is calculated as
–1

% E = (E–1)*100%, where E = 10 slope .
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4.3.3. Serum Analysis
No significant differences for interaction or main effects were observed for serum levels
of two pro–inflammatory markers, CRP and TNF–α, and one anti–inflammatory marker IL–10.
All standards fit the standard curves well and all sample values were within the highest and
lowest standards. Table 4.8 shows the results for these three serum inflammation markers.
Table 4.8. Serum inflammation markers.
Pooled p–value
Variables
WG
AC
5%
10%
15%
20%
SEM
(F)1
C–reactive protein
260830 274760 307690 284570 244440 249740 16428 0.8826
(ng/ml)
Interleukin–10 (pg/ml) 10.9373 14.7208 9.09
9.4265 16.1375 6.943 0.4397 0.5762
Tumor necrosis factor–α
3.5918 3.9132 4.5262 3.9654 4.9518 4.5658 1.7338 0.9502
(pg/ml)
1
An ANOVA F–test p<0.05 indicates a significant measurement with † superscript denoting
significant differences when compared individually to WG.
4.4. Discussion
We hypothesized that significant increases in fermentation and beneficial health effects
would be observable in as low as the 5% whole grain resistant starch treatment level. We used
lean Zucker Diabetic Fatty (ZDF) rats in this study because we wanted to further test the whole
grain resistant starch product and obese ZDF rats previously fermented whole grain resistant
starch better than the isolated resistant starch. In our previously unpublished study, Sprague
Dawley rats fermented the isolated resistant starch product better than the whole grain version.
Another reason for using the lean ZDF rats rather than the obese was to be able to observe
reduced abdominal fat with the better fermentation. Obese ZDF have monogenic obesity based
on a defective gene for their leptin receptor. However, we observed that lean ZDF rats were
heavier than Sprague Dawley rats. In practice, benefits were found to be typically conferred at
5% RS, but depending on the parameter, a minimum of 10% RS was required to elucidate other
benefits in lean ZDF rats.

Unpublished estimates cited in a review article [101] using the
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average weight of food consumed by humans and the average of the average (31.6 g) fiber
requirement for men (38 g) and women (25 g) estimate ~10% of the weight of the diet as fiber
for rats as corresponding to the human fiber requirement.

This was the reason for the

undertaking of the dietary dose response study to move beyond mechanistic, proof–of–concept
studies previously done.

However, high doses of 15% and 20% RS were included for

comparison with previous studies.
Serum markers of inflammation were no different as a response to resistant starch, whole
grain, or dietary fat. The major pro– and anti–inflammatory cytokines, TNF–α and IL–10
respectively, were similar in concentration, suggesting that gut fermentation of the dietary factors
did not alter systemic levels of cytokines. Similarly, as CRP is elevated as a response to
inflammation, no differences in concentration suggests that whole–body inflammation was not
affected by dietary treatments. Studies with human subjects also exhibit inconsistent changes to
markers when consuming dietary RS.

Johnston et al. (2009) reported no changes in

inflammatory markers in insulin resistant subjects, while Gargari et al. (2015) reported
reductions in TNF– α in patients with Type 2 diabetes patients. However in our previous studies,
SD rats do not have a “disordered state” where RS may be able to mediate changes in
inflammatory status. Here, using lean ZDF rats, we observed no differences using transgenic
animals. Future studies using are required to further elucidate the role of fermentable fiber in
altering inflammatory cytokines and proteins.
Biometric
No differences were observed in food or energy intake, inguinal or percent abdominal
body fat when any treatment was compared to the low RS whole grain control. Likened to the
previous study where there were no differences within moderate and high fat diets, all diets being
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isocaloric and equivalent in macronutrient composition had similar response to consumption of
moderate fat diets.

Although we used lean ZDF rats, differences observed in biometric

parameters were driven by resistant starch fermentation, while whole grains alone was typically
numerically better than the non–WG non–RS control (AC, AMIOCA® control).
The observed effects on increased ECW and decreased cecal contents pH illustrate this
trend. Whole grain alone was capable of a response in magnitude in the mean, but did not differ
statistically from the other control. However, at 10% RS and greater, marked differences in
fermentation parameters became apparent. The SCFAs to abilities nourish the gut and gut
microbes (e.g. acetate to butyrate) were significantly different as compared to the whole grain
control. This suggests that although pH and ECW did not change substantially from AMIOCA®
control, the presence of RS1 in the whole grains provided fermentable substrate for the gut
microbes. As a result, the whole grain control was always numerically better (in mean
magnitude) than the AMIOCA® control for production of SCFAs. However, in the case of
whole grain resistant starch, the presence of RS2 complemented fermentation more readily. The
whole grain high RS diet had whole grain flour that is high–amylose starch, and, therefore has a
combination of high–amylose starch RS2 granules and RS1 from the whole grain matrix. This
suggests that gut microbes were not fully capable of accessing the fermentable fiber in the whole
grain matrix but could better utilize the starch granules in the WGRS treatments, though this
finding is speculation and not absolute. Gut microbes utilized the fermentable fiber in increasing
dosage to increase SCFA production. Butyrate production increased with all RS treatments, but
significant differences were observed only at 15% RS and above. As a whole, the benefits from
microbial fermentation seem to be derived from consumption of dietary RS (RS1 and RS2),
where higher doses produce more pronounced effects.
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Gene Expression
Only one gene of the three measured in the gluconeogenesis pathway was increased by
feeding of high RS whole grain. Pyruvate Carboxylase (PC, pyruvate to oxaloacetate), and
glucose–6–phosphatase (G6pc, glucose–6–phosphate to glucose) genes did not differ in
expression as compared to WG. Phosphoenolpyruvate Carboxykinase 1 (PCK1, oxaloacetate to
phosphoenolpyruvate) demonstrated an increased expression when rats were fed the 10% WGRS
diet. In our previous unpublished study (Chapter 3), we observed upregulation of all three genes
measured from the gluconeogenesis pathway in cecal cells when rats were fed dietary RS. Here,
it appears that WGRS only promotes increased gene expression for the major regulatory protein
of the gluconeogenesis pathway [102]. This result may be due to the different strain of rat used.
Sprague Dawley rats displayed increased expression of the three gluconeogenic genes measured.
Increased gluconeogenic activity which correlates to improved insulin sensitivity as hepatic
gluconeogenesis is reduced [103]. It is possible, that increased gene expression of the major
regulatory enzyme may be enough to increase gluconeogenesis.

Further studies would be

required to elucidate this. However, lean ZDF rats may not produce as much glucose via the
gluconeogenic pathway.
Uptake of produced SCFAs is partly facilitated by monocarboxylate transporters located
on the epithelial plasma membrane. Butyrate, the main energy source for the colonocytes, is
increased by gut fermentation and provides an abundance of energy for the microbial community
and is utilized by epithelial cells.

Increased expression of monocarboxylate transporter 1

(MCT1) illustrates increased capacity for uptake of SCFAs, and may improve gut health and
possibly health of the whole body [26]. We observed inconsistent expression of the transporters
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when rats were fed WGRS and the greatest expression occurred for rats fed isolated non–RS
starch. Fermentation of 5% and 20% RS provided an eight to nine–fold increase, respectively, in
expression over WG, while AC increased over ten–fold. As other genes examined were not
different from WG, these findings suggest that WG is less capable of inducing gene expression
than an isolated high RS product in our previously unpublished study. The alternative is that
protein expression may have increased without a concomitant increase in gene expression. This
result may be due to the fact that the current study used lean ZDF rats rather than Sprague
Dawley rats which were used in our previously unpublished study. The benefits of whole grain
consumption in our current study appear to be limited to biometric parameters rather than to
alterations in gene expression. Ravussin et al. (2012) demonstrated correlations with inguinal
adipose adipokines (ANGPTL4, IL–10, TNF–α, and SLC25A25) that were negatively correlated
with increases in bacterial genus Allobaculum [8]. Unlike the measurements in cecal cells, RNA
extracted from inguinal adipose required additional cleanup and concentration steps to obtain
appropriate quality. We expect to find similar results once selection techniques for reference
genes are refined.
Measureable benefits to gut health through feeding diets that included fermentable fibers
were observed. Dietary resistant starch and whole grains improve gut health through microbial–
induced fermentation. All WGRS dosages tested improved fermentation parameters, but
recommendations for optimal health benefits appear to manifest primarily at ~10–15% weight of
diet as fermentable fiber. Consumption of fiber at the dietary reference intake recommended
levels has the potential to improve gut health and can indirectly lead to the improvement of
whole body health.
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CHAPTER 5. VARIABILITY IN REFERENCE GENE EXPRESSION DUE
TO DIETARY RESISTANT STARCH TREATMENTS
5.1. Introduction
Though most foodstuffs are typically digested in the stomach and small intestine, some
components in foods may escape digestion and reach the lower gut. Food components, such as
fermentable fibers, that reach the lower gut may provide substrates for gut microbes. Gut
microbes ferment these fibers and release many bioactive molecules that, if absorbed into the
host’s blood, may invoke metabolic responses. These molecules can affect tissues throughout
the body by providing therapeutic or protective responses by affecting metabolic pathways [87–
89].
Gene expression has become a popular way to enumerate internal responses in the host to
biological and environmental stimuli. Gene expression has shown that nutrients and other food
compounds can stimulate or inhibit transcription of genes [104]. Patterns of expression, as a
response to food consumption, are also important for insights into many biological pathways.
Real–time quantitative reverse transcription polymerase chain reaction (RT–qPCR) analyses
have become the tool of choice to elucidate these outcomes, but are dependent upon accurate and
validated normalization techniques.
Normalization occurs by adjusting the expression of the target gene to a common scale
through use of endogenous controls. Afterwards, comparisons between treatments are allowed to
determine if any independent variables have benefits or harm. The expression of endogenous
controls should remain stable for individual samples, treatment groups or time points.
Theoretically, the only difference in the endogenous control would be differences in pipetting.
This occurred with Northern gel blots with two radioactive RNA probes used for the same lane
of the gel. However, unless there is multiplexing, the endogenous control from the same sample
79

is assessed in a separate well on the plate for real time RT–qPCR. By using triplicate replicates,
pipetting errors are likely minimized. Our molecular lab had been using Cyclophilin–F (PPIF)
for several years, before we began research with resistant starch (RS). We have reported gene
expression using Cyclophilin–F as the endogenous control for many years comparing RS versus
control groups [91, 105, 106]. For validation of a gene array study, we used a panel of 94 genes
from the array (each in separate wells and 4 samples per 384 well plate). The analysis by a
scientist from Applied Biosystems (now Life Technologies within ThermoFisher, Waltham, MA)
made use of the 18S rRNA as the reference cDNA after a separate reverse transcription for each
sample [91]. Proper validation of endogenous controls, which are now referred to as reference
genes (RGs), is an absolute requirement for any meaningful outcome. Many report variability in
commonly used RGs for gene expression analyses [107–110].
Many options are available for RGs selection. Although only one RG is required to
provide meaningful results, the impetus for use of single RG normalization has diminished.
Selecting multiple RGs provides use of newer strategies that require validation of reference
genes, or defining geometric mean to centralize expression to an unbiased average [67].
With the expansion of new foods, fibers, and supplements available commercially,
detecting changes to the current and previous suitability of common RGs will be necessary. In
this study, we examine if consumption of dietary bioactive components may alter gene
expression of two commonly used RGs and analyze their expression in cecal epithelial cells.
This allows the further consideration of single RG normalizations, the prospect of multiple RG
validation techniques, and utilizing central tendency of multiple RG for expression analyses.
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5.2. Methods
Study Design
The study was performed as a three–way ANOVA with the following factors: Resistant
starch (Present or Absent), Whole Grain (WG: Present or Absent), and FAT (FAT: Moderate or
High). Combinations of the three factors were cross classified to make eight diets, all using one
level of each factor (RS: RS/NRS, WG: WG/NWG, FAT: MF/HF). Four isocaloric moderate fat
treatments: NRSNWGMF (CONM), NRSWGMF (WGCM), RSNWGMF (HAMRSM),
RSWGMF (HMWGM); and four isocaloric high fat treatments: NRSNWGHF (CONH),
NRSWGHF (WGCH), RSNWGHF (HAMRSM), RSWGHF (HMWGH) resulted.
Animals and diets
Ninety–six male Sprague Dawley rats were purchased from Envigo (Somerset, NJ) at six
weeks of age, and maintained on a chow diet during a one week quarantine. Rats were then
stratified randomly by body weight into eight groups (n=12, average 259±8.4 grams). Animals
were allowed ad libitum access to food and water for six weeks. Food intake, food spilled, and
body weight were measured twice per week. Rats were euthanized and exsanguinated by cardiac
puncture after inhalation of isoflurane anesthesia delivered by soaked cotton balls. The
gastrointestinal (GI) tract was removed from the base of the esophagus to the anus, separated into
individual parts (stomach, small intestine, cecum, and large intestine) and weighed full and
empty. Cells lining the ceca were flash frozen in liquid N2 and stored at –80°C until later
analysis. RNA was extracted from cecal cells using the RNeasy Mini Kit (Qiagen, Valencia,
CA).
Gene Expression Analysis
TaqMan® Gene Expression Assays (ThermoFisher, Waltham, MA) were used to measure
intestinal gluconeogenesis (IGN) (glucose–6–phosphatase (G6pc), pyruvate carboxylase (PC),
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phosphoenolpyruvate carboxykinase 1 (PCK1)), colonic barrier and goblet cell function (UDP–
galactose–4–epimerase (GALE), monocarboxylate transporter member 1 (MCT1),

mucin 1

(MUC1)), and response to oxidative stress (adrenomedullin (ADM)) in cecal cells and
normalized using Cyclophilin–F (PPIF) or 18S rRNA (TaqMan® Gene Expression Assays;
ThermoFisher, Waltham, MA).
Concentration of extracted RNA was determined using a NanoDropTM ND–1000
microvolume spectrophotometer (ThermoFisher, Waltham, MA). Samples were diluted to 40
ng/µl, and 3 µl combined with 6 µl TaqMan™ Universal Master Mix II, no uracil–N–
glycosylase (UNG) (Applied BiosystemsTM, Waltham, MA), 0.05 µl MuLV RT Transcriptase,
0.05 µl RNase inhibitor, 0.6 µl of the TaqMan® Gene Expression Assay primers and probe, and
0.3 µl of double distilled water. The complete reaction mixture (10 µl) was incubated in an ABI
PRISM 7000HT Sequence Detection System (Applied Biosystems, Foster City, USA) with the
following thermal profile: Stage 1: 1 cycle, 30 min at 48ºC, Stage 2: 1 cycle 10 min at 95ºC,
Stage 3: 40 cycles, 15 sec at 95ºC, 1 min at 60ºC.
Quantification of RGs was determined by pooling aliquots of extracted RNA from all
samples, and using ten–fold dilutions for development of standard curves, The standard curves
were set up as cycles to threshold (Ct) on the Y axis and ng arbitrary RNA on the X axis. The
real time RT–qPCR was done as a one–step procedure with a reverse transcriptase step for
conversion of RNA to cDNA prior to qPCR. With each PCR cycle the cDNA is doubled.
Standards or samples with greater amounts of starting mRNA for a gene reach an arbitrarily set
threshold in fewer cycles than standards or samples with lower amounts of starting mRNA.
For individual samples, target genes and RGs were measured in separate plate wells with
each measured in triplicate wells. Generally, it is recommended to have samples reach the
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threshold between 5 to 35 PCR cycles. RNA samples for PPIF were diluted 1:2.5 and 3 µl used
in the qPCR mix; for 18S rRNA, samples were diluted 1:4.
Statistical Analysis
Statistical analysis was performed using Statistical Analysis Software SAS® version 9.4
(SAS Institute Inc., Cary, NC, USA). Absolute quantity of arbitrary RNA and Ct were examined
for each RG prior to normalization with gene targets in cecal epithelial cells. Ct values were
analyzed for variation in RG expression. A 2x2x2 factorial analysis was performed using the
MIXED procedure.

The three factors for were described above in “Animals and Diets.” The

model used the three factors as fixed effects, and did not use random effects. The linear model
tested was:
Y = β0 + β1X1 + β2X2 + β3X3 + β12X1X2 + β13X1X3 + β23X2X3 + β123X1X2X3 + ϵ
where {

𝑅𝑆
1 𝑊𝐺
1
𝐻𝐹
1
X ={ ,{
X = { , and {
X = { . Denominator degrees of freedom for
𝑁𝑅𝑆 1
0 𝑁𝑊𝐺 2
0
𝑀𝐹 3
0

fixed effects used the Kenward–Roger approximation. An F–test with p<0.05 was considered
statistically significant for interactions and main effects. A p–value less than 0.05 will be
indicative of non–stable RG gene expression for treatment groups.
Homogeneity of variance and influence diagnostics were tested within the MIXED
procedure, while tests for normality were conducted using the UNIVARIATE procedure. A null
model likelihood ratio test (χ2) was performed determine if variance was homogeneous or
heterogeneous.

If variance was homogeneous, then normality testing of residual values used

pooled group residuals. Heterogeneous variance proceeded with variance calculated for each
group. Influential outliers, tested using studentized residuals and leverage, were removed only if
their presence prevented normal distribution for statistical analysis. Influences on parameter
estimates were examined using Cook’s D. Data from dependent variables that violated the
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normality assumption were transformed to log10. Following log10 transformation, normality and
homogeneity of variance testing were reapplied. Data violating the normality assumption after
transformation was considered not normally distributed and reverted to raw data.

When no

significant interactions were observed, only the main effect was reported.
5.3. Results
Both RGs examined had a normal distribution (p>0.05 for Shapiro–Wilk test) and did not
require transformation.

There were no influential outliers or leverage measurements.

Amplification and efficiency for RT–qPCR is reported in Table 5.1.

Standard curves for

reference genes had good amplification and slopes and percent efficiency were within acceptable
ranges, –3.1 to –3.6 and 90 to 110% respectively.
Table 5.1. RT–qPCR amplification efficiency of reference genes.
Standard Curve Equation
(R2)
% Efficiency2
Variables
(y=Ct)1
18s rRNA
–3.4034 * (X) + 9.87
0.9892
97
Cyclophilin–F
–3.5852 * (X) + 26.35
0.9934
90
1
Linear equation of standard curve where Ct = (m)*X + b; m = slope, Ct = cycles to threshold on
Y axis, b = y–intercept; solve for copy number (X) which is in terms of arbitrary RNA.
2
The variable % Efficiency is the amplification efficiency. % Efficiency is calculated as
–1

% E = (E–1)*100%, where E = 10 slope .
No interactions for 18S rRNA Ct were observed for the study: RS*WG (F1,85 = 3.45, p >
0.05), RS*Fat (F1,85 = 0.26, p > 0.50), WG*Fat (F1,85 = 0.61, p > 0.10), and RS*WG*Fat (F1,85 =
2.35, p > 0.10). No interactions for PPIF Ct were observed for the study: RS*WG (F1,81 = 0.04, p
> 0.50), RS*Fat (F1,81 = 0.01, p > 0.50), WG*Fat (F1,81 = 0.10, p > 0.50), and RS*WG*Fat (F1,81
= 0.41, p > 0.50). The 18s rRNA and PPIF Ct were significant for the RS main effect (F1,85 =
16.03, p < 0.0001) and (F1,81 = 30.35, p < 0.0001), respectively. No other main effect was
significant: 18s rRNA (WG, (F1,85 = 3.05, p > 0.05), FAT: (F1,85 = 3.14, p > 0.05)), PPIF (WG,
(F1,81 = 0.82, p > 0.05), FAT (F1,81 = 1.66, p > 0.20)). Main and two–way interaction Ct values
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are shown in Table 5.2. Raw Ct values differed for each rat and did not correspond directly from
18s rRNA to PPIF genes. Figure 5.1 illustrates the distribution values for Ct per rat before
statistical analyses were performed. A difference of one Ct corresponds to a doubling of starting
material (PPIF: mRNA, 18S: rRNA) when comparing the higher Ct to the lower Ct (e.g. 12 vs.
11 for 18S rRNA), as Ct is measured in log2 fold change (212 vs. 211).
Table 5.2. RT–qPCR Ct two–way interaction and main effects for reference genes1,2.
RS * WG Interaction
RS
RS
NRS
NRS
Pooled p–value
Reference Gene (Ct)
WG
NWG
WG
NWG
SEM
(F)2
18s rRNA
11.3078
11.2870
11.7125
12.3926
0.0943 0.0666
Cyclophilin–F
21.7381
21.8815
22.8038
23.0229
0.1002 0.8506
RS * FAT Interaction
RS
RS
NRS
NRS
Pooled p–value
MF
HF
MF
HF
SEM
(F) 2
18s rRNA
11.1788
11.4161
11.8370
12.2681
0.0943 0.6087
Cyclophilin–F
21.6710
21.9486
22.7938
23.0330
0.1002 0.9239
WG * FAT Interaction
WG
WG
NWG
NWG
Pooled p–value
MF
HF
MF
HF
SEM
(F) 2
18s rRNA
11.4168
11.6035
11.5989
12.0807
0.0943 0.4361
Cyclophilin–F
22.1741
22.3678
22.2907
22.6137
0.1002 0.7478
Resistant Starch
p–value
Present
Absent
Pooled SEM
(F) 2
18s rRNA
11.2974
12.0525
0.0954
<0.0001†
Cyclophilin–F
21.8098
22.9134
0.1013
<0.0001†
Whole Grain
p–value
Present
Absent
Pooled SEM
(F) 2
18s rRNA
11.5102
11.8398
0.0949
0.0841
Cyclophilin–F
22.2710
22.4522
0.1008
0.3683
FAT
p–value
Moderate
High
Pooled SEM
(F) 2
18s rRNA
11.5079
11.8421
0.0949
0.0799
Cyclophilin–F
22.4908
22.2324
0.1008
0.2009
1
Data are shown as collapsed interactions based on factors resistant starch (RS, Present [RS] or
Absent [NRS]), whole grains (WG, Present [WG] or Absent [NWG]) and fat (FAT, High [HF]
or Moderate [MF]).
2
A ANOVA F–test p<0.05 indicates a significant measurement, denoted with the † symbol.
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Figure 5.1. Illustration of Ct distribution of values per rat for 18s rRNA and Cyclophilin–F genes.
Measurements are depicted by the same groups and order in A. and B. Measurements are
exaggerated (i.e. do not start at 0) to be able to illustrate differences between individual rats,
treatment groups, and reference genes.
5.4. Discussion
Upon analyzing RG Ct prior to use for normalization of target genes, we discovered a
significant effect of RS when using PPIF. To our knowledge, this has not been reported in
studies using high–amylose maize resistant starch when measuring gene expression.

This

finding represents a two–fold difference in expression when using the PPIF to normalize target
genes with resistant starch groups. This difference becomes an inherent bias against resistant
starch fed groups when comparing expression of target genes. Lower Ct values denote higher
amounts of initial transcripts in the sample. Samples with resistant starch have more transcripts
initially, such that when quantitation is performed the assumption that starting transcript
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concentration being equivalent is violated. The reason for this bias against the resistant starch
treatments is because we use a standard curve in every study and determine quantities in ng of
arbitrary RNA, which are non–log numbers. Normalization is then accomplished by division by
a greater number for resistant starch group samples versus non– resistant starch group samples.
The bias is further present in the normalization for gene targets, such that normalizing with PPIF
gives a biased result for total quantity of complementary DNA. The normalization expression
utilizes the absolute quantity of the target gene and divides it by the absolute quantity of the RG.
As proper reference gene expression is not affected by treatment, the bias discovered here will
propagate through all subsequent genes normalized with PPIF. These errors can be further
compounded when examining multiple tissues.
To counteract this bias, we examined another typical RG, 18s rRNA gene expression, for
normalization. Unfortunately, the use of 18s rRNA also resulted in bias against resistant starch
fed groups, indicating the need to find a truly constitutively expressed RG when using dietary
resistant starch, or another approach to normalization. However, our findings indicate that even
with a bias against resistant starch fed groups, gene expression is still robust with resistant starch
treatments. Target genes have exhibited fold–changes of 2x to 10x even with RG bias against
resistant starch. Interactions and main effects that were nearly significant in our prior studies
may prove to be significant if better normalization techniques were utilized. Additionally, other
commonly examined genes may be tested with resistant starch treatments to determine stability
and suitability as reference genes. A low density array plate with replicate wells with probe and
primers for many candidate RGs can be used to find RGs for treatments versus controls. The
generated Ct values will be compared to other candidates, selecting the most stably expressed
genes to produce accurate results. Future studies could employ both of these plates to provide an
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accurate representation of gene expression when feeding dietary resistant starch or testing
treatments that affect commonly used reference genes. Custom plates can be used with several
RGs for studies to determine global mean expression (described below), however, use of custom
plates may be too costly for many labs. The best approach may be to use many RGs (~32) on
routinely produced plates for endogenous assays to find single RGs or groups of RGs for each
study. This would also be cost–prohibitive for most labs.
Recently, new techniques have been introduced to specifically address issues with
normalization. Global mean expression normalization (GMN) or common base normalization
may suffice for unstable expression of RGs. Gene stability, GMN, is a normalization factor
based on averaging to develop the geometric mean of multiple RG [67]. Multiple RGs should be
used, instead of a single gene, to calculate a normalization factor for normalization of target
genes. Vandesompele et al. (2002) describe the potential for erroneous normalization (3–fold to
6–fold) when single RG normalization strategies are performed [67]. These approaches all
develop a single mean value for a group of RGs. Thus, a possible approach in our study may be
to use the average of PPIF or 18S rRNA for all samples as our normalization factor; or the
average of the combination of both RGs.
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CHAPTER 6. CONCLUSIONS
These investigations demonstrate the importance of studying food components, such as
resistant starch, whole grains, and levels of fat, and their interactions, rather than examining
specific outcomes from single factors. In the first study, there were fermentation differences
between rodents fed high resistant starch in moderate fat diets compared to high fat diets. This
result was similar to previous studies, mirroring significant differences between rodents fed low
fat and high fat diets. The differences occurred in diets without whole grain. With whole grain
diets the fermentation of high resistant starch was similar for moderate fat and high fat diets.
However, the whole grain high resistant starch groups had similar fermentation effects for both
moderate and high fat diets, which were also similar to the group fed high resistant starch with
no whole grain as part of a high fat diet. Since this level of fermentation is still significantly
greater than groups with no resistant starch (non–whole grain control) or low resistant starch as
resistant starch type 1 (whole grain control), these results suggest that Americans may be able to
consume the higher levels of dietary fat (42% of energy).

About 25% of the American

population [1] consuming a high fat diet apparently would still benefit from consumption of
resistant starch. High fat diets may attenuate fermentation, but the addition of other bioactive
components, provided by a whole grain high resistant starch product, were hypothesized to help
maintain the fermentation process. Although gut health was improved with whole grain high
resistant starch diets as demonstrated by increased fermentation compared to low resistant starch
(as resistant starch type 1), whole grain resistant starch diets did not ferment as well as resistant
starch with the feeding of moderate fat. This suggests that, although the two different products
with high resistant starch had the same amount of resistant starch, the combination of resistant
starch type 1 and resistant starch type 2 present in the whole grain kernel compared to an
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equivalent amount of resistant starch as non–whole grain high resistant starch is not as effective
as the isolated starch with high resistant starch all as RS2. Since the scientific literature indicates
that resistant starch type 1 takes longer to be fermented by gut bacteria, we may have missed its
fermentative effects because we focused only on the cecum. The current results indicate that
future studies using whole grain high resistant starch products, should measure fermentation
effects in the rest of the large intestine in addition to the cecum. Continued fermentation along a
greater length of the large intestine would be advantageous to gut health and, thus, would favor
the use of the high resistant starch whole grain product. However, in the cecum, the whole grain
product appears to increase butyrate levels compared to the non–whole grain high resistant starch
product and may benefit the health of the colonocytes that use butyrate as a source of energy.
Increased butyrate may indicate a greater utilization of acetate for butyrate production resulting
in lower cecal acetate that was observed.

The results from this study and our previous

investigations also may indicate that there may be variation in response to dietary resistant starch
in a whole grain product for humans as observed in rodent studies.
Although there were some effects of the whole grain and fat factors that included two–
way interactions (WG*RS and WG*Fat), the dominant factor in the first study was the RS factor.
In particular, the presence of high dietary resistant starch (no whole grain or whole grain) versus
no resistant starch in no whole grain control or low resistant starch type 1 only in the whole grain
control. The whole grain control groups had no resistant starch type 2 because the starch
component of waxy whole grain flour has 100% amylopectin and no amylose with the latter in
granules making up resistant starch type 2. Thus, high resistant starch stood out despite the
interactions and has been addressed thoroughly in the results and discussion.
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In the first study the single factor, resistant starch, was also responsible for most
differences observed in cecal cell gene expression. Resistant starch fermentation induced
significantly increased beneficial gene expression changes. Increased gluconeogenic capacity
apparently promoted by intestinal fermentation of dietary resistant starch may improve insulin
sensitivity and glucose homeostasis. The improved ability to provide nourishment to the gut,
mediate oxidative stress, potentially further induce angiogenesis, and fortification of the
epithelial lining were benefits indicated by increased cecal cell gene expression from dietary
resistant starch fermentation.
The other factors, whole grain and fat, were associated with some changes in gene
expression, but no significant interactions were noted. Whole grains may be capable of eliciting
an improved insulin sensitivity response as cecal cell glucose production may lead to inhibition
of liver gluconeogenesis, potentially through the major gluconeogenic regulatory enzyme
phosphoenolpyruvate carboxykinase (PCK1). However, gene expression of other enzymes in the
gluconeogenesis pathway was not significantly increased by the presence of whole grain.
However, PCK1 increase may be the only increase necessary for increased gluconeogenesis. To
better determine these results future studies should measure not only gene expression, but also
protein levels of the enzymes and potentially production of radioactive glucose from radioactive
oxaloacetate (starting metabolite for gluconeogenesis) in primary cultures of cecal cells.
Additionally, whole grain high resistant starch diets appeared to be beneficial for uptake of
SCFAs with increased expression of SCFA transporters, and along with increased production of
butyrate may promote the health of the upper large intestine, the cecum. Diets high in fat
attenuated the ability of the gut to maintain increased amounts of gene transcripts for SCFA
transporters. This suggests the contributions to gut fermentation and whole body health were
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driven primarily by fermentation of fibers that reached the cecum in our study. While whole
grain promoted increased levels of a few products of gene expression including gene expression
for gluconeogenesis and uptake of butyrate, resistant starch type 2 with its granular form
appeared to be more readily accessible for fermentation in the cecum than the resistant starch
type 1 and resistant starch type 2 combination or resistant starch type 1 alone in the whole grain
control groups.

There may be other pathways where the consumption of whole grains and fat

are beneficial as factors, however resistant starch was the major modulator of biometric and gene
expression parameters measured in the current first study. In future studies, scientists may wish
to include measurement of gene expression of pathways that may be potentially affected by fat
and also gene expression in the distal large intestine.
Future studies should continue to investigate fermentative effects and especially effects
of fermentation on body fat in a variety of rodent models. Our previous study with obese Zucker
Diabetic Fatty (ZDF) rats demonstrated that this rodent model fermented the whole grain high
resistant starch product in the cecum better than the non–whole grain starch with high resistant
starch. However, no reduction in abdominal body fat caused us to switch to Sprague Dawley
(SD) rats that we had used in several previous studies using the non–whole grain high resistant
starch product, and had observed reduction in abdominal body fat. We hypothesized that we
would see better fermentation of the whole grain high resistant starch product and reduced
abdominal body fat. Thus, our result of greater fermentation of the non–whole grain high
resistant starch product by the SD rats was unexpected. The SD rat better models the vast
majority of the American population than the obese ZDF rats, which are a model of monogenic
obesity having a defect in their leptin receptor. Monogenic obesity in humans exists, but this
population is very small. Since the SD rat model has a contrasting effect with feeding of a high
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fat diet with some becoming obese and others remaining relatively lean, researchers and
companies have developed colonies of obesity–prone and obesity–resistant rats. The obesity–
prone SD rats are obese when consuming a high fat diet because of a poorly understood
interaction of several genes and thus are a multigenic model, which models the majority of the
obese human population.
For the second study, we did not want to give up on the possibility of the whole grain
high resistant starch product so lean ZDF rats were chosen for the dose response. It was
anticipated they would ferment the high resistant starch whole grain product similarly to their
related obese ZDF rats. Since the lean ZDF rats had a functioning leptin receptor, it was also
hypothesized that the lean ZDF rats would respond to fermentation with reduced abdominal body
fat.
In the second study, it appeared that the lean ZDF rats were better fermenters of the high
resistant starch whole grain product. However, we did not do a comparison with the non–whole
grain high resistant starch product or a comparison with SD rats. The key result for the dose
response study was that we demonstrated effective dietary doses for fermentation and these were
at physiologically relevant doses as related to human consumption. Several dependent variables
had significant outcomes versus the whole grain control group for all doses of whole grain
resistant starch even at the lowest dose of 5%. With other variables, the 5% RS dose was not
significantly different from the whole grain control, but its value was in line with the increases of
the other three doses. Thus, it is not clear exactly, which is the lowest effective dose of whole
grain resistant starch. Our aim was to assign that designation to the lowest dose that was
significantly different from the whole grain control. Depending on the dependent variable, 5%
RS fits that designation, but for one (ECW) it is 10% RS. One interesting result occurred with
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butyrate levels in cecal contents where only 10, 15 and 20% whole grain resistant starch had
significantly greater amounts than the whole grain control. The dose of 10% whole grain
resistant starch is equivalent to the human fiber requirement when using the dry weight of daily
food consumption and metabolic body size of the rat and the human [101]. Therefore, in regards
to fermentation parameters, our study successfully demonstrated that doses of whole grain
resistant starch at or below the equivalent of the human fiber requirement were effective.
One unexpected result for our second study with lean ZDF rats was that there was no
reduction in body fat with any of the doses of whole grain resistant starch. In the first study, a
whole grain resistant starch level of 23% resulted in reduced abdominal body fat in SD rats. Our
observation (no statistical comparison) was that it appeared that the lean ZDF rats had more body
fat than SD rats. An interesting future study would be to compare the lean ZDF rats with the SD
rats using the dose response approach; and to use both the whole grain resistant starch product as
well as the isolated starch with high resistant starch type 2.
In both of our studies, use of whole grain resistant starch, whether in a dose response of
5, 10, 15 or 20% RS, or a single dose of 23% RS resulted in limited benefits as far as increased
gene expression for apparent health promoting proteins. The high single dose increased levels of
messenger RNA for the PCK1 and MCT1 genes. Results were inconsistent with doses in our
second study and may be due changing from SD to lean ZDF rats or possibly experimental error.
Future studies are also needed to determine how isolated starch with resistant starch and
whole grain resistant starch products will most benefit the host by measuring other dependent
variables than in our current two studies. Our studies have successfully demonstrated the whole
grain resistant starch is an effective product for fermentation in the cecum in both moderate and
high fat diets. Other studies may want to focus on following other compounds in the whole grain
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product with moderate and high fat diets. It was encouraging to observe that there was a healthy
amount of fermentation on the high fat diet, which was in the upper range of consumption of
dietary fat typically consumed by Americans. Thus, the consumption of adequate amounts of
fermentable fiber in recommended amounts in the form of isolated starch with resistant starch or
whole grain resistant starch appears to be a very good approach to promote health benefits.
More studies are needed to determine if this is enough to declare that under these dietary
circumstances an individual would be relatively healthy.
The availability of the whole grain corn flour for these studies, provided by Ingredion
Incorporated, has been discontinued, primarily as a result of instability and shorter shelf life.
The whole grain corn flour requires a cool, dry, relatively airtight storage location to minimize
enzymatic activity on oils found in the germ resulting in spoilage. Shelf life degradation is
further enhanced by heat, light, and moisture. From a purely fermentation perspective, the whole
grain components were unnecessary as the resistant starch fermentable fiber component appears
to promote fermentation in the cecum. This parallels findings by Cho et al. (2013), which
suggest that the fiber component of whole grains is the most important and accounts for most of
the whole grain health benefit. Our studies show that isolated starch with resistant starch (as
resistant starch type 2) ferments well and is believed to store relatively indefinitely. However,
future studies should not forgo the use of whole grains. Govers et al. (1999) determined that
whole grain starch is fermented slowly and exhibits greater fermentation in the distal colon. This
would indicate that utilization of resistant starch type1 in the whole grain matrix may produce
regional fermentation that reduces risk of colorectal cancers in the distal colon, where most colon
cancers occur [39].
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Whole grains also contain other metabolically active components and discarding their
use may serve to limit knowledge on the activity of whole grains for improving health. Future
research stabilizing the volatile and labile components of whole grains may improve shelf life
and allow for long–term storage for greater use in studies and may result in demonstration of
future beneficial health effects. From our study and other studies the resistant starch components
of the whole grain product appeared to be stable. Teaming with food scientists to develop
stabilization methods for whole grain corn flour may allow for further utilization of both resistant
starch types 1 and 2 to promote fermentation in both the proximal and distal colon. Studies
successfully demonstrating stabilization of whole grain flour would warrant restoring the
availability of whole grain corn flour to consumers. Likewise, investigation into the stability of
non–corn whole grain sources (e.g. barley, oats, rice, wheat, etc.), may also be fruitful and
reduce limitations to procuring and examining their effects on metabolism if the availability of
whole grain corn flour remains discontinued.
In summary: Our two studies have demonstrated beneficial health effects from
consuming dietary resistant starch and have added important results to the body of knowledge
regarding its fermentative and metabolic effects, and our results demonstrate that the effects
measured in our studies were likely due to the amount of resistant starch fermentable fiber and
not the result of other bioactive compounds in the whole grain resistant starch product. Our first
study with Sprague Dawley rats, demonstrated that isolated starch with resistant starch type 2
fermented better than whole grain resistant starch with resistant starch types 1 and 2 with the
feeding of a moderate fat diet. To better investigate the whole grain flour, lean ZDF rats were
used in the second study with increasing doses of the high resistant starch whole grain flour. Our
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results demonstrated that lower doses that are physiologically relevant for humans were effective
in producing beneficial health effects in regard to fermentation in rats.
Future studies should also examine fecal matter repeatedly during the study to discern
fermentation effects of resistant starch type 1 from whole grain flour from available sources in
the distal colon. These studies would examine the entire large intestine as a fermentative organ.
These should also include the characterization of microbes in the entire colon at euthanasia of the
animals, to delineate the differences in resistance starch types 1 and 2. These studies should be
performed in different types of rats that respond to the whole grain with variable degrees of
fermentation. Dose response studies with different non–whole grain and whole grain sources, a
variety of rats and mice, and different levels of fermentable fiber will be necessary to validate the
recommendations proposed to consumers.
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